Skip Navigation
Skip to contents

Intest Res : Intestinal Research

IMPACT FACTOR

Previous issues

Page Path
HOME > Browse articles > Previous issues
24 Previous issues
Filter
Filter
Article category
Keywords
Authors
Funded articles
Volume 16(3); July 2018
Prev issue Next issue
Editorial
IBD
The importance of immunization in immune-mediated inflammatory disease cannot be overstated
Sang Hyoung Park
Intest Res 2018;16(3):325-326.   Published online July 27, 2018
DOI: https://doi.org/10.5217/ir.2018.16.3.325
PDFPubReaderePub
  • 4,872 View
  • 86 Download
Close layer
Focused Review: Colorectal Cancers
Colorectal neoplasia
Genetic and epigenetic alterations of colorectal cancer
Sung Noh Hong
Intest Res 2018;16(3):327-337.   Published online July 27, 2018
DOI: https://doi.org/10.5217/ir.2018.16.3.327
AbstractAbstract PDFPubReaderePub

Colorectal cancer (CRC) arise from multi-step carcinogenesis due to genetic mutations and epigenetic modifications of human genome. Genetic mutations and epigenetic modifications were originally established as 2 independent mechanisms contributing to colorectal carcinogenesis. However, recent evidences demonstrate that there are interactions between these 2 mechanisms. Genetic mutations enable disruption of epigenetic controls while epigenetic modifications can initiate genomic instability and carcinogenesis. This review summarized genetic mutations and epigenetic modifications in colorectal carcinogenesis and molecular classification of CRC subtype based on genetic or epigenetic biomarkers for treatment response and prognosis. Molecular subtypes of CRC will permit the implementation of precision medicine with better outcome of management for CRC.

Citations

Citations to this article as recorded by  
  • Unveiling Commonalities and Differences in Genetic Regulations via Two-Way Fusion
    Biao Mei, Yu Jiang, Yifan Sun
    Journal of Computational Biology.2024; 31(9): 834.     CrossRef
  • Potential molecular mechanisms of myrtenal against colon cancer: A systematic review
    Lokesh Kumar Boopathy, Anitha Roy, Thiyagarajan Gopal, Rakhee Rathnam Kalari Kandy, Madan Kumar Arumugam
    Journal of Biochemical and Molecular Toxicology.2024;[Epub]     CrossRef
  • Long-term effects of the Hebei Spirit oil spill on the prevalence and incidence of allergic disorders
    Se Hyun Hwang, Yong-Jin Lee, Yun-Hee Choi, Da-An Huh, Min-Sung Kang, Kyong Whan Moon
    Science of The Total Environment.2024; 912: 168801.     CrossRef
  • Development and validation of epigenetic modification-related signals for the diagnosis and prognosis of colorectal cancer
    Xia Li, Jingjing Li, Jie Li, Nannan Liu, Liwei Zhuang
    BMC Genomics.2024;[Epub]     CrossRef
  • Decoding the regulatory landscape of lncRNAs as potential diagnostic and prognostic biomarkers for gastric and colorectal cancers
    Arefeh Zabeti Touchaei, Sogand Vahidi, Ali Akbar Samadani
    Clinical and Experimental Medicine.2024;[Epub]     CrossRef
  • Circulating Nucleic Acids in Colorectal Cancer: Diagnostic and Prognostic Value
    Somayeh Igder, Mozhdeh Zamani, Shima Fakher, Morvarid Siri, Hassan Ashktorab, Negar Azarpira, Pooneh Mokarram, Sowjanya Thatikonda
    Disease Markers.2024; 2024: 1.     CrossRef
  • The Crucial Roles of Diet, Microbiota, and Postbiotics in Colorectal Cancer
    Rüya Kuru-Yaşar, Özlem Üstün-Aytekin
    Current Nutrition Reports.2024; 13(2): 126.     CrossRef
  • Plasma-Derived Extracellular Vesicles and Non-Extracellular Vesicle Components from APCMin/+ Mice Promote Pro-Tumorigenic Activities and Activate Human Colonic Fibroblasts via the NF-κB Signaling Pathway
    Luis A. Arteaga-Blanco, Andrew E. Evans, Dan A. Dixon
    Cells.2024; 13(14): 1195.     CrossRef
  • Discovery and validation of colorectal cancer tissue-specific methylation markers: a dual-center retrospective cohort study
    Qinxing Cao, Zhenjia Dan, Nengyi Hou, Li Yan, Xingmei Yuan, Hejiang Lu, Song Yu, Jiangping Zhang, Huasheng Xiao, Qiang Liu, Xiaoyong Zhang, Min Zhang, Minghui Pang
    Clinical Epigenetics.2024;[Epub]     CrossRef
  • Identification of an m6A‐related lncRNA prognostic signature in colorectal cancer
    Zhi‐Liang Shi, Xiaoling Yang, Cheng‐Long Shen, Guo‐Qiang Zhou
    Journal of Biochemical and Molecular Toxicology.2023;[Epub]     CrossRef
  • IDH2, a novel target of OGT, facilitates glucose uptake and cellular bioenergy production via NF-κB signaling to promote colorectal cancer progression
    Xiaoli He, Nan Wu, Renlong Li, Haohao Zhang, Yu Zhao, Yongzhan Nie, Jing Wu
    Cellular Oncology.2023; 46(1): 145.     CrossRef
  • Correlated downregulation of VDR and CYP3A4 in colorectal cancer
    Hossein Sadeghi, Veys Hashemnia, Ehsan Nazemalhosseini-Mojarad, Mohammad Reza Ghasemi, Reza Mirfakhraie
    Molecular Biology Reports.2023; 50(2): 1385.     CrossRef
  • Multi-omics insights into the interplay between gut microbiota and colorectal cancer in the “microworld” age
    An-Jun Wang, Dingka Song, Yue-Mei Hong, Ning-Ning Liu
    Molecular Omics.2023; 19(4): 283.     CrossRef
  • Development of a Novel DNA Aptamer Targeting Colorectal Cancer Cell‐Derived Small Extracellular Vesicles as a Potential Diagnostic and Therapeutic Agent
    Byung Seok Cha, Young Jun Jang, Eun Sung Lee, Do Yeon Kim, Ji Su Woo, Jinseo Son, Seokjoon Kim, Jiye Shin, Jinjoo Han, Seokhwan Kim, Ki Soo Park
    Advanced Healthcare Materials.2023;[Epub]     CrossRef
  • Interaction of lncRNAs with mTOR in colorectal cancer: a systematic review
    Marziyeh Sadat Moslehian, Roya Shabkhizan, Mohammad Reza Asadi, Ahad Bazmani, Mahdi Mahdipour, Sanya Haiaty, Reza Rahbarghazi, Ebrahim Sakhinia
    BMC Cancer.2023;[Epub]     CrossRef
  • Hypermethylated GRIA4, a potential biomarker for an early non-invasive detection of metastasis of clinically known colorectal cancer
    Eva Lukacova, Tatiana Burjanivova, Petar Podlesniy, Marian Grendar, Eva Turyova, Ivana Kasubova, Ludovit Laca, Peter Mikolajcik, Eva Kudelova, Andrea Vanochova, Juraj Miklusica, Sandra Mersakova, Zora Lasabova
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Diagnostic value of methylated branched chain amino acid transaminase 1/IKAROS family zinc finger 1 for colorectal cancer
    Ke Xu, Ai-Ru Yu, Shen-Bin Pan, Jie He
    World Journal of Gastroenterology.2023; 29(36): 5240.     CrossRef
  • Lansoprazole as a potent HDAC2 inhibitor for treatment of colorectal cancer: An in-silico analysis and experimental validation
    Saedeh Khadempar, Marzieh Lotfi, Fatemeh Haghiralsadat, Massoud Saidijam, Nasrin Ghasemi, Saeid Afshar
    Computers in Biology and Medicine.2023; 166: 107518.     CrossRef
  • Unveiling the genetic and epigenetic landscape of colorectal cancer: new insights into pathogenic pathways
    Humzah Postwala, Yesha Shah, Priyajeet S. Parekh, Mehul R. Chorawala
    Medical Oncology.2023;[Epub]     CrossRef
  • Assessing the Correlation between Helicobacter Pylori Infection and Increased Incidence of Colorectal Cancer, Gastric Atrophy, and Intestinal Metaplasia
    Kubilay İŞSEVER, Ali MUHTAROĞLU, Furkan Ali UYGUR, Muhammet Burak KAMBUROGLU
    Medical Records.2023; 5(Supplement): 22.     CrossRef
  • Functional Proteomics Characterization of the Role of SPRYD7 in Colorectal Cancer Progression and Metastasis
    Ana Montero-Calle, Sofía Jiménez de Ocaña, Ruth Benavente-Naranjo, Raquel Rejas-González, Rubén A. Bartolomé, Javier Martínez-Useros, Rodrigo Sanz, Jana Dziaková, María Jesús Fernández-Aceñero, Marta Mendiola, José Ignacio Casal, Alberto Peláez-García, Ro
    Cells.2023; 12(21): 2548.     CrossRef
  • The platinum coordination complex inhibits cell invasion-migration and epithelial-to-mesenchymal transition by altering the TGF-β-SMAD pathway in colorectal cancer
    Maha-Hamadien Abdulla, Aminah Ahmad Alzailai, Mansoor-Ali Vaali-Mohammed, Rehan Ahmad, Sabiha Fatima, Ahmed Zubaidi, Thamer bin Traiki, Amer Mahmood, Reem Hamoud Alrashoudi, Zahid Khan
    Frontiers in Pharmacology.2023;[Epub]     CrossRef
  • Integrated bioinformatics approach to unwind key genes and pathways involved in colorectal cancer
    Syeda Anjum Mobeen, Pallavi Saxena, Arun Kumar Jain, Ravi Deval, Khateef Riazunnisa, Dibyabhaba Pradhan
    Journal of Cancer Research and Therapeutics.2023; 19(7): 1766.     CrossRef
  • cGAS–STING signaling pathway in gastrointestinal inflammatory disease and cancers
    Xinxin Ke, Tao Hu, Mizu Jiang
    The FASEB Journal.2022;[Epub]     CrossRef
  • Assessment of tumor burden and response to therapy in patients with colorectal cancer using a quantitative ctDNA test for methylated BCAT1/IKZF1
    Erin L. Symonds, Susanne K. Pedersen, Bernita Yeo, Hiba Al Naji, Susan E. Byrne, Amitesh Roy, Graeme P. Young
    Molecular Oncology.2022; 16(10): 2031.     CrossRef
  • Krill oil supplementation reduces the growth of CT-26 orthotopic tumours in Balb/c mice
    Abilasha Gayani Jayathilake, Elif Kadife, Nyanbol Kuol, Rodney Brain Luwor, Kulmira Nurgali, Xiao Qun Su
    BMC Complementary Medicine and Therapies.2022;[Epub]     CrossRef
  • Predicted miRNAs suppressed cell proliferation and migration via FAK/VASP axis; Systems biology approach
    Asghar Mohammadi, Ghasem Ghasempour, Abbas Sahebghadam Lotfi, Mohammad Najafi
    Informatics in Medicine Unlocked.2022; 29: 100890.     CrossRef
  • The potential of PIK3CA, KRAS, BRAF, and APC hotspot mutations as a non-invasive detection method for colorectal cancer
    Maryam Alizadeh-Sedigh, Habibollah Mahmoodzadeh, Mohammad Sadegh Fazeli, Mohammad Haddadi-Aghdam, Ladan Teimoori-Toolabi
    Molecular and Cellular Probes.2022; 63: 101807.     CrossRef
  • Epigenetics and its Therapeutic Potential in Colorectal Cancer
    Mahsa Akbari Oryani, Afsaneh Tavasoli, Mohammad Amin Ghalavand, Rahele Zokaei Ashtiani, Alisam Rezaee, Rasadokht Mahmoudi, Hossein Golvari, Soroor Owrangi, Mehdi Soleymani-Goloujeh
    Epigenomics.2022; 14(11): 683.     CrossRef
  • Role of gene regulation and inter species interaction as a key factor in gut microbiota adaptation
    Shuang Gao, Muhammad Imran Khan, Fadia Kalsoom, Zhen Liu, Yanxin Chen, Zhengli Chen
    Archives of Microbiology.2022;[Epub]     CrossRef
  • Identification of a Genomic Instability-Related Long Noncoding RNA Prognostic Model in Colorectal Cancer Based on Bioinformatic Analysis
    Yu Liang, Hong-Xu Sun, Bin Ma, Qing-Kai Meng, Luca Falzone
    Disease Markers.2022; 2022: 1.     CrossRef
  • Novel multiplex stool-based assay for the detection of early-stage colon cancer in a Chinese population
    Hui-Hong Jiang, Si-Wei Xing, Xuan Tang, Ying Chen, Kang Lin, Lu-Wei He, Mou-Bin Lin, Er-Jiang Tang
    World Journal of Gastroenterology.2022; 28(24): 2705.     CrossRef
  • Genetic and epigenetic dependencies in colorectal cancer development
    Sehej Parmar, Hariharan Easwaran
    Gastroenterology Report.2022;[Epub]     CrossRef
  • Fecal biomarkers: Non-invasive diagnosis of colorectal cancer
    Qian Ding, Xiangxu Kong, Weilong Zhong, Wentian Liu
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Long-term prognosis of curative endoscopic submucosal dissection for early colorectal cancer according to submucosal invasion: a multicenter cohort study
    Jongbeom Shin, Eun Ran Kim, Hyun Joo Jang, Dong Hoon Baek, Dong-Hoon Yang, Bo-In Lee, Kwang Bum Cho, Jin Woong Cho, Sung-Ae Jung, Su Jin Hong, Bong Min Ko, Jung-Won Jeon, Weon Jin Ko, Sun Moon Kim, Young Dae Kim, Kim Chan Gyoo, Gwang Ho Baik, In Kyung Yoo
    BMC Gastroenterology.2022;[Epub]     CrossRef
  • Chemotherapy induces feedback up-regulation of CD44v6 in colorectal cancer initiating cells through β-catenin/MDR1 signaling to sustain chemoresistance
    Shibnath Ghatak, Vincent C. Hascall, Nikos Karamanos, Roger R. Markwald, Suniti Misra
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Role of CTLA4 immunohistochemistry in the diagnosis of colon cancers
    Vishnu Narayanan, V Pavithra, Divya Dhanapal, Sandhya Sundaram, C. D Narayanan
    Indian Journal of Pathology and Microbiology.2022; 65(4): 791.     CrossRef
  • The potential value of miRNA-223 as a diagnostic biomarker for Egyptian colorectal patients
    Noha G. Bader El Din, Sally Farouk, Lubna O. Abdel-Salam, Ahmed Khairy
    European Journal of Gastroenterology & Hepatology.2021; 33(1): 25.     CrossRef
  • Role of gut microbiota in epigenetic regulation of colorectal Cancer
    Yinghui Zhao, Chuanxin Wang, Ajay Goel
    Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2021; 1875(1): 188490.     CrossRef
  • SIRT4 is the molecular switch mediating cellular proliferation in colorectal cancer through GLS mediated activation of AKT/GSK3β/CyclinD1 pathway
    Ying Cui, Yibing Bai, Jiani Yang, Yuanfei Yao, Chunhui Zhang, Chao Liu, Jiaqi Shi, QingWei Li, Jingchun Zhang, Xiaolin Lu, Yanqiao Zhang
    Carcinogenesis.2021; 42(3): 481.     CrossRef
  • Doubling the Dose of Bevacizumab Beyond Progression in Metastatic Colorectal Cancer–the Experience of a Tertiary Cancer Center
    Călin Căinap, Ovidiu-Vasile Bochiş, Cătălin Vlad, Raluca Popita, Patriciu Achimaş-Cadariu, Andrei Havasi, Andreea Vidrean, Alexandra Dranca, Andra Piciu, Anne-Marie Constantin, Tiberiu Tat, Maniu Dana, Ovidiu Crişan, Cosmin Vasile Cioban, Ovidiu Bălăcescu
    Frontiers in Pharmacology.2021;[Epub]     CrossRef
  • A novel proteomics approach to epigenetic profiling of circulating nucleosomes
    Priscilla Van den Ackerveken, Alison Lobbens, Jean-Valery Turatsinze, Victor Solis-Mezarino, Moritz Völker-Albert, Axel Imhof, Marielle Herzog
    Scientific Reports.2021;[Epub]     CrossRef
  • Role of Stress-Survival Pathways and Transcriptomic Alterations in Progression of Colorectal Cancer: A Health Disparities Perspective
    Urbashi Basnet, Abhijeet R. Patil, Aditi Kulkarni, Sourav Roy
    International Journal of Environmental Research and Public Health.2021; 18(11): 5525.     CrossRef
  • Patient-derived tumor models: a more suitable tool for pre-clinical studies in colorectal cancer
    Giulia Rizzo, Andrea Bertotti, Simonetta Maria Leto, Stefania Vetrano
    Journal of Experimental & Clinical Cancer Research.2021;[Epub]     CrossRef
  • Exosomes miR-22-3p Derived from Mesenchymal Stem Cells Suppress Colorectal Cancer Cell Proliferation and Invasion by Regulating RAP2B and PI3K/AKT Pathway
    Yan Wang, Changkun Lin, Alamgeer Yuchi
    Journal of Oncology.2021; 2021: 1.     CrossRef
  • Prognostic Score Model Based on Ten Differentially Methylated Genes for Predicting Clinical Outcomes in Patients with Adenocarcinoma of the Colon
    Gongping Sun, He Duan, Yuanhao Xing, Dewei Zhang
    Cancer Management and Research.2021; Volume 13: 5113.     CrossRef
  • Oral Delivery of Nucleic Acids with Passive and Active Targeting to the Intestinal Tissue Using Polymer-Based Nanocarriers
    Sagun Poudel, Prabhat R. Napit, Karen P. Briski, George Mattheolabakis
    Pharmaceutics.2021; 13(7): 1075.     CrossRef
  • Promising Epigenetic Biomarkers for the Early Detection of Colorectal Cancer: A Systematic Review
    Sorina Andreea Anghel, Corina-Bianca Ioniță-Mîndrican, Ioana Luca, Anca Lucia Pop
    Cancers.2021; 13(19): 4965.     CrossRef
  • Survival effect of probiotics in a rat model of colorectal cancer treated with capecitabine
    Graciela Gigola, Pedro Carriere, María Belén Novoa Díaz, Gabriela Perdigon, Ariel Osvaldo Zwenger, Claudia Gentili
    World Journal of Gastrointestinal Oncology.2021; 13(10): 1518.     CrossRef
  • Reviewing cancer’s biology: an eclectic approach
    Ibrahim Diori Karidio, Senay Hamarat Sanlier
    Journal of the Egyptian National Cancer Institute.2021;[Epub]     CrossRef
  • Gene Therapy Targeting p53 and KRAS for Colorectal Cancer Treatment: A Myth or the Way Forward?
    Hidayati Husainy Hasbullah, Marahaini Musa
    International Journal of Molecular Sciences.2021; 22(21): 11941.     CrossRef
  • Colon Cancer-Related Genes Identification and Function Study Based on Single-Cell Multi-Omics Integration
    Xuepu Sun, Yu Guo, Yu Zhang, Peng Zhao, Zhaoqing Wang, Zheng Wei, Haiquan Qiao
    Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
  • Epistatic effect of TLR3 and cGAS‐STING‐IKKε‐TBK1‐IFN signaling variants on colorectal cancer risk
    Calogerina Catalano, Miguel Inacio da Silva Filho, Christoph Frank, Shun Lu, Katerina Jiraskova, Veronika Vymetalkova, Miroslav Levy, Vaclav Liska, Ondrej Vycital, Alessio Naccarati, Ludmila Vodickova, Kari Hemminki, Pavel Vodicka, Alexander N. R. Weber,
    Cancer Medicine.2020; 9(4): 1473.     CrossRef
  • Proteomic investigations into resistance in colorectal cancer
    David I. Cantor, Harish R. Cheruku, Jack Westacott, Joo-Shik Shin, Abidali Mohamedali, Seong Boem Ahn
    Expert Review of Proteomics.2020; 17(1): 49.     CrossRef
  • Potential Use of Biotherapeutic Bacteria to Target Colorectal Cancer-Associated Taxa
    Garreth W. Lawrence, Máire Begley, Paul D. Cotter, Caitriona M. Guinane
    International Journal of Molecular Sciences.2020; 21(3): 924.     CrossRef
  • Clinical outcomes of submucosal colorectal cancer diagnosed after endoscopic resection: a focus on the need for surgery
    Yun Sik Choi, Wan Soo Kim, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, Seung-Jae Myung, Suk-Kyun Yang, Jeong-Sik Byeon
    Intestinal Research.2020; 18(1): 96.     CrossRef
  • Low-dose naltrexone inhibits colorectal cancer progression and promotes apoptosis by increasing M1-type macrophages and activating the Bax/Bcl-2/caspase-3/PARP pathway
    Mingxing Ma, Xiaonan Wang, Ning Liu, Fengping Shan, Yong Feng
    International Immunopharmacology.2020; 83: 106388.     CrossRef
  • Personalized Medicine—Current and Emerging Predictive and Prognostic Biomarkers in Colorectal Cancer
    Christine Koulis, Raymond Yap, Rebekah Engel, Thierry Jardé, Simon Wilkins, Gemma Solon, Jeremy D. Shapiro, Helen Abud, Paul McMurrick
    Cancers.2020; 12(4): 812.     CrossRef
  • Novel biomarkers for the diagnosis and prognosis of colorectal cancer
    Hyung-Hoon Oh, Young-Eun Joo
    Intestinal Research.2020; 18(2): 168.     CrossRef
  • A novel epigenetic signature to predict recurrence-free survival in patients with colon cancer
    Qi-xin Dai, Yong-hui Liao, Xiao-hong Deng, Xiu-lin Xiao, Long Zhang, Lin Zhou
    Clinica Chimica Acta.2020; 508: 54.     CrossRef
  • Strategies to Increase the Participation Rate of Colorectal Cancer Screening
    Yoon Suk Jung
    Gut and Liver.2020; 14(3): 277.     CrossRef
  • Epigenetic Therapies in the Precision Medicine Era
    Michel Lopes Leite, Kamila Botelho Sampaio de Oliveira, Victor Albuquerque Cunha, Simoni Campos Dias, Nicolau Brito da Cunha, Fabricio F. Costa
    Advanced Therapeutics.2020;[Epub]     CrossRef
  • mTOR Signaling Combined with Cancer Stem Cell Markers as a Survival Predictor in Stage II Colorectal Cancer
    Ji Young Chang, Jae Hyun Kim, Joyeon Kang, Yehyun Park, Soo Jung Park, Jae Hee Cheon, Won Ho Kim, Hoguen Kim, Jae Jun Park, Tae Il Kim
    Yonsei Medical Journal.2020; 61(7): 572.     CrossRef
  • Survival Benefit of Palliative Primary Tumor Resection Based on Tumor Location in Patients with Metastatic Colorectal Cancer: A Single-center Retrospective Study
    Jae Hyun Kim, Sol Jin, Min Ji Jeon, Hyun Yeb Jung, Sanghwan Byun, Kyoungwon Jung, Sung Eun Kim, Won Moon, Moo In Park, Seun Ja Park
    The Korean Journal of Gastroenterology.2020; 76(1): 17.     CrossRef
  • USP18 directly regulates Snail1 protein through ubiquitination pathway in colorectal cancer
    Fakun Huang, Chengying Zheng, Longkai Huang, Changqing Lin, Jiaxing Wang
    Cancer Cell International.2020;[Epub]     CrossRef
  • RNA-binding protein CELF1 enhances cell migration, invasion, and chemoresistance by targeting ETS2 in colorectal cancer
    Huaiming Wang, Rongkang Huang, Wentai Guo, Xiusen Qin, Zifeng Yang, Zixu Yuan, Yingqi Wei, Chunlin Mo, Zhantao Zeng, Jian Luo, Jian Cai, Hui Wang
    Clinical Science.2020; 134(14): 1973.     CrossRef
  • P2X7R promotes angiogenesis and tumour‐associated macrophage recruitment by regulating the NF‐κB signalling pathway in colorectal cancer cells
    Chunhui Yang, Shuang Shi, Ying Su, Jing‐Shan Tong, Liangjun Li
    Journal of Cellular and Molecular Medicine.2020; 24(18): 10830.     CrossRef
  • Fecal DNA methylation markers for detecting stages of colorectal cancer and its precursors: a systematic review
    Janhavi R. Raut, Zhong Guan, Petra Schrotz-King, Hermann Brenner
    Clinical Epigenetics.2020;[Epub]     CrossRef
  • Integrative Analysis of the IQ Motif-Containing GTPase-Activating Protein Family Indicates That the IQGAP3-PIK3C2B Axis Promotes Invasion in Colon Cancer


    Zhuo Liu, Xiao Li, Jie Ma, Dechuan Li, Haixing Ju, Yong Liu, Yinbo Chen, Xujun He, Yuping Zhu
    OncoTargets and Therapy.2020; Volume 13: 8299.     CrossRef
  • Long Non-coding RNA LINC00115 Contributes to the Progression of Colorectal Cancer by Targeting miR-489-3p via the PI3K/AKT/mTOR Pathway
    Weiyu Feng, Baodong Li, Jinbang Wang, Huiliang Zhang, Yonggang Liu, Dongli Xu, Ke Cheng, Jing Zhuang
    Frontiers in Genetics.2020;[Epub]     CrossRef
  • Analysis of microRNA-34a expression profile and rs2666433 variant in colorectal cancer: a pilot study
    Manal S. Fawzy, Afaf T. Ibrahiem, Baraah T. Abu AlSel, Saleh A. Alghamdi, Eman A. Toraih
    Scientific Reports.2020;[Epub]     CrossRef
  • Drug Response Associated With and Prognostic lncRNAs Mediated by DNA Methylation and Transcription Factors in Colon Cancer
    Jiayu Zhang, Zhen Shen, Zheyu Song, Jian Luan, Yezhou Li, Tiancheng Zhao
    Frontiers in Genetics.2020;[Epub]     CrossRef
  • The SP1-Induced Long Noncoding RNA, LINC00339, Promotes Tumorigenesis in Colorectal Cancer via the miR-378a-3p/MED19 Axis


    Hua Ye, Wende Li, Kefeng Wu, Yi Liu, Yingnian Lv, Yuzhen Zhu, Hui Luo, Liao Cui
    OncoTargets and Therapy.2020; Volume 13: 11711.     CrossRef
  • Outcomes of stent insertion and mortality in obstructive stage IV colorectal cancer patients through 10 year duration
    Yong Eun Park, Yehyun Park, Soo Jung Park, Jae Hee Cheon, Won Ho Kim, Tae Il Kim
    Surgical Endoscopy.2019; 33(4): 1225.     CrossRef
  • AU-rich element-binding proteins in colorectal cancer
    Noémie Legrand, Dan A Dixon, Cyril Sobolewski
    World Journal of Gastrointestinal Oncology.2019; 11(2): 71.     CrossRef
  • Association between polymorphism in the promoter region of lncRNA GAS5 and the risk of colorectal cancer
    Yajie Wang, Shenshen Wu, Xi Yang, Xiaobo Li, Rui Chen
    Bioscience Reports.2019;[Epub]     CrossRef
  • Exosomes, metastases, and the miracle of cancer stem cell markers
    Zhe Wang, Margot Zöller
    Cancer and Metastasis Reviews.2019; 38(1-2): 259.     CrossRef
  • Drugs Targeting Epigenetic Modifications and Plausible Therapeutic Strategies Against Colorectal Cancer
    Srinivas Patnaik, Anupriya
    Frontiers in Pharmacology.2019;[Epub]     CrossRef
  • Neurexophilin and PC‐esterase domain family member 4 (NXPE4) and prostate androgen‐regulated mucin‐like protein 1 (PARM1) as prognostic biomarkers for colorectal cancer
    Ya‐Rui Liu, Yang Hu, Ying Zeng, Zhi‐Xing Li, Hai‐Bo Zhang, Jun‐Li Deng, Guo Wang
    Journal of Cellular Biochemistry.2019; 120(10): 18041.     CrossRef
  • Identification of differentially expressed genes regulated by methylation in colon cancer based on bioinformatics analysis
    Yu Liang, Cheng Zhang, Dong-Qiu Dai
    World Journal of Gastroenterology.2019; 25(26): 3392.     CrossRef
  • Early-onset Colorectal Cancer
    Mo Ah Jeong, Hyoun Woo Kang
    The Korean Journal of Gastroenterology.2019; 74(1): 4.     CrossRef
  • Immunotherapies and Targeted Therapies in the Treatment of Metastatic Colorectal Cancer
    Prashanth Rawla, Adam Barsouk, Andreas V. Hadjinicolaou, Alexander Barsouk
    Medical Sciences.2019; 7(8): 83.     CrossRef
  • The Expression Profile and Prognostic Significance of Metallothionein Genes in Colorectal Cancer
    Kuo-Chen Hung, Tsui-Chin Huang, Chia-Hsiung Cheng, Ya-Wen Cheng, Ding-Yen Lin, Jhen-Jia Fan, Kuen-Haur Lee
    International Journal of Molecular Sciences.2019; 20(16): 3849.     CrossRef
  • The Intricate Interplay between Epigenetic Events, Alternative Splicing and Noncoding RNA Deregulation in Colorectal Cancer
    Raheleh Amirkhah, Hojjat Naderi-Meshkin, Jaynish Shah, Philip Dunne, Ulf Schmitz
    Cells.2019; 8(8): 929.     CrossRef
  • TRPM7 deficiency suppresses cell proliferation, migration, and invasion in human colorectal cancer via regulation of epithelial-mesenchymal transition
    Fei Su, Bo-Fang Wang, Tao Zhang, Xiao-Ming Hou, Mao-Hui Feng
    Cancer Biomarkers.2019; 26(4): 451.     CrossRef
  • Assessment of Immuno-Histochemical Expression of MBD1 in Colorectal Adenocarcinoma and Its Correlations with Prognostic Factors
    Sholeh Ghaedamini, Mehdi Nikbakht, Mitra Soleimani
    Middle East Journal of Digestive Diseases.2019; 12(1): 39.     CrossRef
  • Promising Antineoplastic Actions of Melatonin
    Gaia Favero, Enrico Moretti, Francesca Bonomini, Russel J. Reiter, Luigi Fabrizio Rodella, Rita Rezzani
    Frontiers in Pharmacology.2018;[Epub]     CrossRef
  • 12,835 View
  • 344 Download
  • 88 Web of Science
  • 87 Crossref
Close layer
Colorectal neoplasia
Intestinal microbiota, chronic inflammation, and colorectal cancer
Chan Hyuk Park, Chang Soo Eun, Dong Soo Han
Intest Res 2018;16(3):338-345.   Published online July 27, 2018
DOI: https://doi.org/10.5217/ir.2018.16.3.338
AbstractAbstract PDFPubReaderePub

In addition to genetic and epigenetic factors, various environmental factors, including diet, play important roles in the development of colorectal cancer (CRC). Recently, there is increasing interest in the intestinal microbiota as an environmental risk factor for CRC, because diet also influences the composition of the intestinal microbiota. The human intestinal microbiota comprises about 100 trillion microbes. This microbiome thrives on undigested dietary residues in the intestinal lumen and produces various metabolites. It is well known that the dietary risk factors for CRC are mediated by dysbiosis of the intestinal microbiota and their metabolites. In this review, we describe the bacterial taxa associated with CRC, including Fusobacterium nucleatum, enterotoxigenic Bacteroides fragilis, Escherichia coli, and butyrate-producing bacteria. We also discuss the host-diet interaction in colorectal carcinogenesis.

Citations

Citations to this article as recorded by  
  • Composition of the colon microbiota in the individuals with inflammatory bowel disease and colon cancer
    Ceren Acar, Sibel Kucukyildirim Celik, H. Ozgur Ozdemirel, Beril Erdem Tuncdemir, Saadet Alan, Hatice Mergen
    Folia Microbiologica.2024; 69(2): 333.     CrossRef
  • Role of Probiotics against Human Cancers, Inflammatory Diseases, and Other Complex Malignancies
    Hammad Naeem, Hammad Ul Hassan, Muhammad Shahbaz, Muhammad Imran, Anjuman Gul Memon, Ammarah Hasnain, Shamas Murtaza, Suliman A. Alsagaby, Waleed Al Abdulmonem, Muzzamal Hussain, Mohamed A. Abdelgawad, Mohammed M. Ghoneim, Entessar Al Jbawi, Rafik Balti
    Journal of Food Biochemistry.2024; 2024: 1.     CrossRef
  • The State-of-the-Art Mechanisms and Antitumor Effects of Somatostatin in Colorectal Cancer: A Review
    Aldona Kasprzak, Agnieszka Geltz
    Biomedicines.2024; 12(3): 578.     CrossRef
  • Association of gut microbiome with immune microenvironment in surgically treated colorectal cancer patients
    Nayoung Han, Hee Jin Chang, Hyun Yang Yeo, Byung Chang Kim, Bun Kim, Sung Chan Park, Jeongseon Kim, Ji Won Park, Jae Hwan Oh
    Pathology.2024; 56(4): 528.     CrossRef
  • The Cross-talk Between Intestinal Microbiota and MDSCs Fuels Colitis-associated Cancer Development
    Hadas Ashkenazi-Preiser, Or Reuven, Atara Uzan-Yulzari, Sharon Komisarov, Roy Cirkin, Sondra Turjeman, Carmel Even, Nira Twaik, Kerem Ben-Meir, Ivan Mikula, Leonor Cohen-Daniel, Yaron Meirow, Eli Pikarsky, Yoram Louzoun, Omry Koren, Michal Baniyash
    Cancer Research Communications.2024; 4(4): 1063.     CrossRef
  • A Potential Role of Xenometabolites as Nutraceutical: A Concurrent Review
    Sunanda Biswas, Ali Imran, Fakhar Islam, Muhammad Umair Arshad, Iqra Aslam, Mohd Asif Shah, Umber Shehzadi, Ifrah Usman, zza Faiz UL Rasool, Safura Aslam
    Current Research in Nutrition and Food Science Journal.2024; 12(1): 20.     CrossRef
  • TLR4/NF-kB/β-Catenin/TGF-β pathways in Salmonella AvrA related-Colorectal Cancer Tumorigenesis
    Bogi Pratomo Wibowo, Handono Kalim, Husnul Khotimah, Hidayat Sujuti, Ettie Rukmigarsari
    Research Journal of Pharmacy and Technology.2024; : 2597.     CrossRef
  • Association of Helicobacter pylori infection with colorectal polyps/adenomas: A single-center cross-sectional study
    Lan Chen, Rongrong Cao, Jie Han, Honglu Yu, Yingchao Li, Xiaomin Wang, Jiang Chen, Xingshun Qi
    Cancer Epidemiology.2024; 92: 102626.     CrossRef
  • Interactions between toll‐like receptors signaling pathway and gut microbiota in host homeostasis
    Luping Chen, Linfang Zhang, Hua Hua, Li Liu, Yuejian Mao, Ruirui Wang
    Immunity, Inflammation and Disease.2024;[Epub]     CrossRef
  • Collective neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio symbolizes a new prognostic factor in the survival of gastric cancer patients
    Sareh Mohammadi, Zeinab Veisi, Mohammad Moazeni, Soleiman Kheiri, Zahra Lorigooini, Roholah Masomi
    Journal of Shahrekord University of Medical Sciences.2024; 26(2): 51.     CrossRef
  • Autophagy and the Insulin-like Growth Factor (IGF) System in Colonic Cells: Implications for Colorectal Neoplasia
    Aldona Kasprzak
    International Journal of Molecular Sciences.2023; 24(4): 3665.     CrossRef
  • The Colorectal Cancer Gut Environment Regulates Activity of the Microbiome and Promotes the Multidrug Resistant Phenotype of ESKAPE and Other Pathogens
    Matthew T. F. Lamaudière, Ramesh Arasaradnam, Gareth D. Weedall, Igor Y. Morozov, Vincent B. Young
    mSphere.2023;[Epub]     CrossRef
  • Bacteroides fragilis Toxin Induces Cleavage and Proteasome Degradation of E-cadherin in Human Breast Cancer Cell Lines BT-474 and MCF7
    Da-Hye KANG, Sang-Hyeon YOO, Ju-Eun HONG, Ki-Jong RHEE
    Korean Journal of Clinical Laboratory Science.2023; 55(1): 37.     CrossRef
  • Editorial: Targeting the microbiota to attenuate chronic inflammation
    Elena Moreno, Marius Trøseid, Ivan Vujkovic-Cvijin, Giulia Marchetti, Laura Martín-Pedraza, Sergio Serrano-Villar
    Frontiers in Immunology.2023;[Epub]     CrossRef
  • Anti-tumour effect of Huangqin Decoction on colorectal cancer mice through microbial butyrate mediated PI3K/Akt pathway suppression
    Jia-Jie Zhu, Hai-Yan Liu, Liang-Jun Yang, Zheng Fang, Rui Fu, Jia-Bin Chen, Shan Liu, Bao-Ying Fei
    Journal of Medical Microbiology .2023;[Epub]     CrossRef
  • Disease‐associated gut microbiome and critical metabolomic alterations in patients with colorectal cancer
    Hongze Zhang, Kai Jin, Kunlong Xiong, Wenwen Jing, Zhen Pang, Meng Feng, Xunjia Cheng
    Cancer Medicine.2023; 12(14): 15720.     CrossRef
  • Cellular and Molecular Mechanisms of the Tumor Stroma in Colorectal Cancer: Insights into Disease Progression and Therapeutic Targets
    Nikolay Shakhpazyan, Liudmila Mikhaleva, Arkady Bedzhanyan, Zarina Gioeva, Nikolay Sadykhov, Alexander Mikhalev, Dmitri Atiakshin, Igor Buchwalow, Markus Tiemann, Alexander Orekhov
    Biomedicines.2023; 11(9): 2361.     CrossRef
  • Impact of Diet on Colorectal Cancer Progression and Prevention: From Nutrients to Neoplasms
    Sang Hoon Kim, Dong Hwan Park, Yun Jeong Lim
    The Korean Journal of Gastroenterology.2023; 82(2): 73.     CrossRef
  • Microbial dysbiosis and epigenetics modulation in cancer development – A chemopreventive approach
    Shafiul Haque, Ritu Raina, Nazia Afroze, Arif Hussain, Ahmad Alsulimani, Vineeta Singh, Bhartendu Nath Mishra, Sanjana Kaul, Ravindra Nath Kharwar
    Seminars in Cancer Biology.2022; 86: 666.     CrossRef
  • A Brief look at antitumor effects of doxycycline in the treatment of colorectal cancer and combination therapies
    Kimia Ghasemi, Kosar Ghasemi
    European Journal of Pharmacology.2022; 916: 174593.     CrossRef
  • Association Between H. pylori Infection and Colorectal Polyps: A Meta-Analysis of Observational Studies
    Depeng Lu, Mingyu Wang, Xiquan Ke, Qiangwu Wang, Jianchao Wang, Dapeng Li, Meng Wang, Qizhi Wang
    Frontiers in Medicine.2022;[Epub]     CrossRef
  • The role of microbiome in colorectal carcinogenesis and its clinical potential as a target for cancer treatment
    Sang Hoon Kim, Yun Jeong Lim
    Intestinal Research.2022; 20(1): 31.     CrossRef
  • A systemic review of the role of enterotoxic Bacteroides fragilis in colorectal cancer
    Nancy Scott, Emma Whittle, Patricio Jeraldo, Nicholas Chia
    Neoplasia.2022; 29: 100797.     CrossRef
  • Ficus dubia Latex Extract Induces Cell Cycle Arrest and Apoptosis by Regulating the NF-κB Pathway in Inflammatory Human Colorectal Cancer Cell Lines
    Rentong Hu, Weerachai Chantana, Pornsiri Pitchakarn, Subhawat Subhawa, Bhanumas Chantarasuwan, Piya Temviriyanukul, Teera Chewonarin
    Cancers.2022; 14(11): 2665.     CrossRef
  • Potential Impacts of Prebiotics and Probiotics on Cancer Prevention
    Saptadip Samanta
    Anti-Cancer Agents in Medicinal Chemistry.2022; 22(4): 605.     CrossRef
  • Archaeome in Colorectal Cancer: High Abundance of Methanogenic Archaea in Colorectal Cancer Patients
    Hosseinali Abdi, Dor Mohammad Kordi-Tamandani, Milad Lagzian, Alireza Bakhshipour
    International Journal of Cancer Management.2022;[Epub]     CrossRef
  • Escherichia coli and Colorectal Cancer: Unfolding the Enigmatic Relationship
    Roghayeh Nouri, Alka Hasani, Kourosh Masnadi Shirazi, Mohammad Reza Alivand, Bita Sepehri, Simin Sotoodeh, Fatemeh Hemmati, Mohammad Ahangarzadeh Rezaee
    Current Pharmaceutical Biotechnology.2022; 23(10): 1257.     CrossRef
  • Synthesis and Evaluation of Some New 4H-Pyran Derivatives as Antioxidant, Antibacterial and Anti-HCT-116 Cells of CRC, with Molecular Docking, Antiproliferative, Apoptotic and ADME Investigations
    Nahed N. E. El-Sayed, Magdi E. A. Zaki, Sami A. Al-Hussain, Abir Ben Bacha, Malika Berredjem, Vijay H. Masand, Zainab M. Almarhoon, Hanaa S. Omar
    Pharmaceuticals.2022; 15(7): 891.     CrossRef
  • Inflammatory bowel disease in Korea: epidemiology and pathophysiology
    Jung Won Lee, Chang Soo Eun
    The Korean Journal of Internal Medicine.2022; 37(5): 885.     CrossRef
  • The Dark Side of Iron: The Relationship between Iron, Inflammation and Gut Microbiota in Selected Diseases Associated with Iron Deficiency Anaemia—A Narrative Review
    Ida J. Malesza, Joanna Bartkowiak-Wieczorek, Jakub Winkler-Galicki, Aleksandra Nowicka, Dominika Dzięciołowska, Marta Błaszczyk, Paulina Gajniak, Karolina Słowińska, Leszek Niepolski, Jarosław Walkowiak, Edyta Mądry
    Nutrients.2022; 14(17): 3478.     CrossRef
  • Cholecystectomy-induced secondary bile acids accumulation ameliorates colitis through inhibiting monocyte/macrophage recruitment
    Yun Liu, Jun Xu, Xinhua Ren, Yu Zhang, Ziliang Ke, Jianhua Zhou, Yang Wang, Yifan Zhang, Yulan Liu
    Gut Microbes.2022;[Epub]     CrossRef
  • Wenzi Jiedu Recipe ameliorates colorectal cancer by remodeling the gut microbiota and tumor microenvironment
    Wenli Qiu, Tianqing Sang, Haibin Chen, Hongli Zhou, Zhongqiu Wang, Hongguang Zhou
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Roles of Gut Microbiota in Colorectal Carcinogenesis Providing a Perspective for Early Diagnosis and Treatment
    Roghayeh Nouri, Alka Hasani, Mohammad Asgharzadeh, Fatemeh Yeganeh Sefidan, Fatemeh Hemmati, Mohammad Ahangarzadeh Rezaee
    Current Pharmaceutical Biotechnology.2022; 23(13): 1569.     CrossRef
  • Gut microbiota alterations are distinct for primary colorectal cancer and hepatocellular carcinoma
    Wei Jia, Cynthia Rajani, Hongxi Xu, Xiaojiao Zheng
    Protein & Cell.2021; 12(5): 374.     CrossRef
  • Toll-like receptor 4 prevents AOM/DSS-induced colitis-associated colorectal cancer in Bacteroides fragilis gnotobiotic mice
    Yen-Peng Lee, Wen-Ching Huang, Tien-Jen Lin, Chien-Chao Chiu, Yu-Chih Wang, Yi-Hsun Chen, Shao-Wen Hung, Hsiao-Li Chuang, Ter-Hsin Chen
    Human & Experimental Toxicology.2021; 40(4): 622.     CrossRef
  • Gut microbiota influence tumor development and Alter interactions with the human immune system
    Yanshan Ge, Xinhui Wang, Yali Guo, Junting Yan, Aliya Abuduwaili, Kasimujiang Aximujiang, Jie Yan, Minghua Wu
    Journal of Experimental & Clinical Cancer Research.2021;[Epub]     CrossRef
  • The Distinctive Serum Metabolomes of Gastric, Esophageal and Colorectal Cancers
    Zhenxing Ren, Cynthia Rajani, Wei Jia
    Cancers.2021; 13(4): 720.     CrossRef
  • Metagenome Analysis of Intestinal Bacteria in Healthy People, Patients With Inflammatory Bowel Disease and Colorectal Cancer
    Yongshun Ma, Yao Zhang, Houxiang Jiang, Shixin Xiang, Yueshui Zhao, Mintao Xiao, Fukuan Du, Huijiao Ji, Parham Jabbarzadeh Kaboli, Xu Wu, Mingxing Li, Qinglian Wen, Jing Shen, Zhongming Yang, Jing Li, Zhangang Xiao
    Frontiers in Cellular and Infection Microbiology.2021;[Epub]     CrossRef
  • Analysis of the intestinal microbiome in colorectal cancer
    B I Gataullin, I G Gataullin, Nguyen Thi Nga, A I Kolpakov, O N Ilinskaya
    Kazan medical journal.2021; 102(2): 185.     CrossRef
  • Astragalin Inhibits the Proliferation and Migration of Human Colon Cancer HCT116 Cells by Regulating the NF-κB Signaling Pathway
    Min Yang, Wen-Yun Li, Jing Xie, Zi-Lin Wang, Yan-Long Wen, Cun-Chao Zhao, Liang Tao, Ling-Fei Li, Yang Tian, Jun Sheng
    Frontiers in Pharmacology.2021;[Epub]     CrossRef
  • Temporal metabolic response yields a dynamic biosignature of inflammation
    Jesse T. Peach, Stephanie M. Wilson, Logan D. Gunderson, Lizzi Frothingham, Tan Tran, Seth T. Walk, Carl J. Yeoman, Brian Bothner, Mary P. Miles
    iScience.2021; 24(8): 102817.     CrossRef
  • Colorectal Cancer Stage-Specific Fecal Bacterial Community Fingerprinting of the Taiwanese Population and Underpinning of Potential Taxonomic Biomarkers
    Chuan-Yin Fang, Jung-Sheng Chen, Bing-Mu Hsu, Bashir Hussain, Jagat Rathod, Kuo-Hsin Lee
    Microorganisms.2021; 9(8): 1548.     CrossRef
  • Association of Helicobacter pylori infection with colorectal adenoma in the Chinese urban population: A cross-sectional study
    Lingyu Shen, Rongwen Bian, Wei Wang, Junning Zhao
    Microbial Pathogenesis.2021; 158: 105111.     CrossRef
  • Multi-scale network targeting: A holistic systems-biology approach to cancer treatment
    Doru Paul, Natalia L. Komarova
    Progress in Biophysics and Molecular Biology.2021; 165: 72.     CrossRef
  • Lipopolysaccharides Enhance Epithelial Hyperplasia and Tubular Adenoma in Intestine-Specific Expression of krasV12 in Transgenic Zebrafish
    Jeng-Wei Lu, Yuxi Sun, Pei-Shi Angelina Fong, Liang-In Lin, Dong Liu, Zhiyuan Gong
    Biomedicines.2021; 9(8): 974.     CrossRef
  • High frequency of enterotoxigenic Bacteroides fragilis and Enterococcus faecalis in the paraffin-embedded tissues of Iranian colorectal cancer patients
    Nasibeh Khodaverdi, Habib Zeighami, Ahmad Jalilvand, Fakhri Haghi, Negar Hesami
    BMC Cancer.2021;[Epub]     CrossRef
  • Function of BCLAF1 in human disease (Review)
    Zongdong Yu, Jie Zhu, Haibiao Wang, Hong Li, Xiaofeng Jin
    Oncology Letters.2021;[Epub]     CrossRef
  • Association Between Carotid Ultrasonography Findings and Colorectal Adenoma in Asymptomatic Adults
    Jeongseok Kim, Ji Young Lee, Nam Seok Ham, Eun Hye Oh, Hye-Sook Chang, Hyewon Park, Yoon Suh Do, Sung Wook Hwang, Dong-Hoon Yang, Jae Won Choe, Jeong-Sik Byeon
    Digestive Diseases and Sciences.2020; 65(6): 1816.     CrossRef
  • Dietary Xanthan Gum Alters Antibiotic Efficacy against the Murine Gut Microbiota and Attenuates Clostridioides difficile Colonization
    Matthew K. Schnizlein, Kimberly C. Vendrov, Summer J. Edwards, Eric C. Martens, Vincent B. Young, Katherine McMahon
    mSphere.2020;[Epub]     CrossRef
  • Enterotoxigenic Bacteroides fragilis: A Possible Etiological Candidate for Bacterially-Induced Colorectal Precancerous and Cancerous Lesions
    Samin Zamani, Reza Taslimi, Akram Sarabi, Seyedesomaye Jasemi, Leonardo A. Sechi, Mohammad Mehdi Feizabadi
    Frontiers in Cellular and Infection Microbiology.2020;[Epub]     CrossRef
  • Risk for Colorectal Neoplasia in Patients With Helicobacter pylori Infection: A Systematic Review and Meta-analysis
    Da Sol Choi, Seung In Seo, Woon Geon Shin, Chan Hyuk Park
    Clinical and Translational Gastroenterology.2020; 11(2): e00127.     CrossRef
  • Metaproteomics characterizes human gut microbiome function in colorectal cancer
    Shuping Long, Yi Yang, Chengpin Shen, Yiwen Wang, Anmei Deng, Qin Qin, Liang Qiao
    npj Biofilms and Microbiomes.2020;[Epub]     CrossRef
  • Gut commensal bacteria, Paneth cells and their relations to radiation enteropathy
    Yan-Li Gao, Li-Hong Shao, Li-Hua Dong, Peng-Yu Chang
    World Journal of Stem Cells.2020; 12(3): 188.     CrossRef
  • Long noncoding RNA ZFAS1 promoting small nucleolar RNA-mediated 2′-O-methylation via NOP58 recruitment in colorectal cancer
    Huizhe Wu, Wenyan Qin, Senxu Lu, Xiufang Wang, Jing Zhang, Tong Sun, Xiaoyun Hu, Yalun Li, Qiuchen Chen, Yuanhe Wang, Haishan Zhao, Haiyan Piao, Rui Zhang, Minjie Wei
    Molecular Cancer.2020;[Epub]     CrossRef
  • The Influence of Caerulomycin A on the Intestinal Microbiota in SD Rats
    Hongwei Zhang, Mengmeng Lan, Guodong Cui, Weiming Zhu
    Marine Drugs.2020; 18(5): 277.     CrossRef
  • Influence of Iron on the Gut Microbiota in Colorectal Cancer
    Oliver Phipps, Hafid O. Al-Hassi, Mohammed N. Quraishi, Aditi Kumar, Matthew J. Brookes
    Nutrients.2020; 12(9): 2512.     CrossRef
  • Multiomics Study of Gut Bacteria and Host Metabolism in Irritable Bowel Syndrome and Depression Patients
    Congmin Xu, Qiong Jia, Lu Zhang, Zhe Wang, Shiwei Zhu, Xiaoqi Wang, Yixuan Liu, Mo Li, Jingjing Zhang, Xiangqun Wang, Jindong Zhang, Qinghua Sun, Kun Wang, Huaiqiu Zhu, Liping Duan
    Frontiers in Cellular and Infection Microbiology.2020;[Epub]     CrossRef
  • The Human OncoBiome Database: A Database of Cancer Microbiome Datasets
    Nadia, Jayashree Ramana
    Current Bioinformatics.2020; 15(5): 472.     CrossRef
  • Microbiota and gastrointestinal cancer
    Meng-Tzu Weng, Yu-Tse Chiu, Ping-Ya Wei, Chien-Wei Chiang, Huei-Ling Fang, Shu-Chen Wei
    Journal of the Formosan Medical Association.2019; 118: S32.     CrossRef
  • Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models
    Susan J. Robertson, Paul Lemire, Heather Maughan, Ashleigh Goethel, Williams Turpin, Larbi Bedrani, David S. Guttman, Kenneth Croitoru, Stephen E. Girardin, Dana J. Philpott
    Cell Reports.2019; 27(6): 1910.     CrossRef
  • Periodontitis is associated with an increased risk for proximal colorectal neoplasms
    Gun Woo Kim, Young-Sang Kim, Soo Hyun Lee, Seung Geon Park, Duk Hwan Kim, Joo Young Cho, Ki Baik Hahm, Sung Pyo Hong, Jun-Hwan Yoo
    Scientific Reports.2019;[Epub]     CrossRef
  • Physical Activity and Inflammation Phenotype Conversion
    Mary P. Miles, Stephanie Wilson, Carl J. Yeoman
    Journal of Clinical Exercise Physiology.2019; 8(2): 64.     CrossRef
  • The clinical application of fruquintinib on colorectal cancer
    Zhongguang Chen, Lili Jiang
    Expert Review of Clinical Pharmacology.2019; 12(8): 713.     CrossRef
  • Study Insights into Gastrointestinal Cancer through the Gut Microbiota
    Fanli Kong, Yi Cai
    BioMed Research International.2019; 2019: 1.     CrossRef
  • Use of Antibiotics and Risk of Cancer: A Systematic Review and Meta-Analysis of Observational Studies
    Fausto Petrelli, Michele Ghidini, Antonio Ghidini, Gianluca Perego, Mary Cabiddu, Shelize Khakoo, Emanuela Oggionni, Chiara Abeni, Jens Claus Hahne, Gianluca Tomasello, Alberto Zaniboni
    Cancers.2019; 11(8): 1174.     CrossRef
  • Functional polymorphisms of the lncRNA H19 promoter region contribute to the cancer risk and clinical outcomes in advanced colorectal cancer
    Wenyan Qin, Xiaodong Wang, Yilin Wang, Yalun Li, Qiuchen Chen, Xiaoyun Hu, Zhikun Wu, Pengfei Zhao, Shanqiong Li, Haishan Zhao, Weifan Yao, Jian Ding, Minjie Wei, Huizhe Wu
    Cancer Cell International.2019;[Epub]     CrossRef
  • The association between fecal enterotoxigenic B. fragilis with colorectal cancer
    Fakhri Haghi, Elshan Goli, Bahman Mirzaei, Habib Zeighami
    BMC Cancer.2019;[Epub]     CrossRef
  • Fusobacterium nucleatum and the Immune System in Colorectal Cancer
    Elena Monica Borroni, Dorina Qehajaj, Floriana Maria Farina, Daniel Yiu, Robert S. Bresalier, Maurizio Chiriva-Internati, Leonardo Mirandola, Sanja Štifter, Luigi Laghi, Fabio Grizzi
    Current Colorectal Cancer Reports.2019; 15(5): 149.     CrossRef
  • Non-alcoholic fatty liver disease and colorectal cancer: A marker of risk or common causation?
    Niki Katsiki, Dimitri P. Mikhailidis, Christos Mantzoros
    Metabolism.2018; 87: A10.     CrossRef
  • 8,679 View
  • 265 Download
  • 69 Web of Science
  • 69 Crossref
Close layer
Colorectal neoplasia
Impact of microbiota in colorectal carcinogenesis: lessons from experimental models
Linda Chia-Hui Yu, Shu-Chen Wei, Yen-Hsuan Ni
Intest Res 2018;16(3):346-357.   Published online July 27, 2018
DOI: https://doi.org/10.5217/ir.2018.16.3.346
AbstractAbstract PDFPubReaderePub

A role of gut microbiota in colorectal cancer (CRC) growth was first suggested in germ-free rats almost 50 years ago, and the existence of disease-associated bacteria (termed pathobionts) had becoming increasingly evident from experimental data of fecal transplantation, and microbial gavage or monoassociation. Altered bacterial compositions in fecal and mucosal specimens were observed in CRC patients compared to healthy subjects. Microbial fluctuations were found at various cancer stages; an increase of bacterial diversity was noted in the adenoma specimens, while a reduction of bacterial richness was documented in CRC samples. The bacterial species enriched in the human cancerous tissues included Escherichia coli, Fusobacterium nucleatum, and enterotoxigenic Bacteroides fragilis. The causal relationship of gut bacteria in tumorigenesis was established by introducing particular bacterial strains in in situ mouse CRC models. Detailed experimental protocols of bacterial gavage and the advantages and caveats of different experimental models are summarized in this review. The microbial genotoxins, enterotoxins, and virulence factors implicated in the mechanisms of bacteria-driven tumorigenesis are described. In conclusion, intestinal microbiota is involved in colon tumorigenesis. Bacteria-targeting intervention would be the next challenge for CRC.

Citations

Citations to this article as recorded by  
  • Mitotic Spindle Positioning (MISP) Facilitates Colorectal Cancer Progression by Forming a Complex with Opa Interacting Protein 5 (OIP5) and Activating the JAK2-STAT3 Signaling Pathway
    Koki Hiura, Masaki Watanabe, Naoki Hirose, Kenta Nakano, Tadashi Okamura, Hayato Sasaki, Nobuya Sasaki
    International Journal of Molecular Sciences.2024; 25(5): 3061.     CrossRef
  • Association of gut microbiome with immune microenvironment in surgically treated colorectal cancer patients
    Nayoung Han, Hee Jin Chang, Hyun Yang Yeo, Byung Chang Kim, Bun Kim, Sung Chan Park, Jeongseon Kim, Ji Won Park, Jae Hwan Oh
    Pathology.2024; 56(4): 528.     CrossRef
  • A Potential Role of Xenometabolites as Nutraceutical: A Concurrent Review
    Sunanda Biswas, Ali Imran, Fakhar Islam, Muhammad Umair Arshad, Iqra Aslam, Mohd Asif Shah, Umber Shehzadi, Ifrah Usman, zza Faiz UL Rasool, Safura Aslam
    Current Research in Nutrition and Food Science Journal.2024; 12(1): 20.     CrossRef
  • Could environmental exposure and climate change Be a key factor in the rising incidence of early onset colorectal cancer?
    Adhari AlZaabi, Hussein A. Younus, Hassan A. Al-Reasi, Rashid Al-Hajri
    Heliyon.2024; 10(16): e35935.     CrossRef
  • Diet-mediated gut microbial community modulation and signature metabolites as potential biomarkers for early diagnosis, prognosis, prevention and stage-specific treatment of colorectal cancer
    Mutebi John Kenneth, Hsin-Chi Tsai, Chuan-Yin Fang, Bashir Hussain, Yi-Chou Chiu, Bing-Mu Hsu
    Journal of Advanced Research.2023; 52: 45.     CrossRef
  • Tissue vs. Fecal-Derived Bacterial Dysbiosis in Precancerous Colorectal Lesions: A Systematic Review
    Jurate Valciukiene, Kestutis Strupas, Tomas Poskus
    Cancers.2023; 15(5): 1602.     CrossRef
  • Human gene and microbial analyses in rectal cancer complete responses to radiotherapy
    Arielle Kae Sulit, Kasmira Wilson, John Pearson, Olin K Silander, Shienny Sampurno, Michael Michael, Robert Ramsay, Alexander Heriot, Frank Frizelle, Rachel Violet Purcell
    BJS Open.2023;[Epub]     CrossRef
  • Ginsenoside Rb1 Suppresses AOM/DSS-induced Colon Carcinogenesis
    Ling Wang, Qing-Qing Zhang, Yu-Yu Xu, Rui Zhang, Qing Zhao, Yu-Qing Zhang, Xue-Hong Huang, Bin Jiang, Min Ni
    Anti-Cancer Agents in Medicinal Chemistry.2023; 23(9): 1067.     CrossRef
  • Gut microbiota and carcinogenesis: actual aspects
    Aleksandr F. Poveshchenko, Valeria N. Cherkas, Aleksey V. Kabakov, Oleg V. Kazakov
    Journal of microbiology, epidemiology and immunobiology.2023; 100(3): 247.     CrossRef
  • Impact of Diet on Colorectal Cancer Progression and Prevention: From Nutrients to Neoplasms
    Sang Hoon Kim, Dong Hwan Park, Yun Jeong Lim
    The Korean Journal of Gastroenterology.2023; 82(2): 73.     CrossRef
  • Risk Factors for Colorectal Polyps
    嫣琦 王
    Advances in Clinical Medicine.2023; 13(09): 14803.     CrossRef
  • Microbiome in Cancer Development and Treatment
    Sona Ciernikova, Aneta Sevcikova, Beata Mladosievicova, Michal Mego
    Microorganisms.2023; 12(1): 24.     CrossRef
  • Invasive Pathobionts Contribute to Colon Cancer Initiation by Counterbalancing Epithelial Antimicrobial Responses
    Linda Chia-Hui Yu, Shu-Chen Wei, Yi-Hsuan Li, Po-Yu Lin, Xin-Yu Chang, Jui-Ping Weng, Yin-Wen Shue, Liang-Chuan Lai, Jin-Town Wang, Yung-Ming Jeng, Yen-Hsuan Ni
    Cellular and Molecular Gastroenterology and Hepatology.2022; 13(1): 57.     CrossRef
  • Epidemiology of Helicobacter pylori
    Amnon Sonnenberg
    Alimentary Pharmacology & Therapeutics.2022;[Epub]     CrossRef
  • The role of microbiome in colorectal carcinogenesis and its clinical potential as a target for cancer treatment
    Sang Hoon Kim, Yun Jeong Lim
    Intestinal Research.2022; 20(1): 31.     CrossRef
  • Emerging role of human microbiome in cancer development and response to therapy: special focus on intestinal microflora
    Hourieh Sadrekarimi, Zhanna R. Gardanova, Morteza Bakhshesh, Farnoosh Ebrahimzadeh, Amirhossein Fakhre Yaseri, Lakshmi Thangavelu, Zahra Hasanpoor, Firoozeh Abolhasani Zadeh, Mohammad Saeed Kahrizi
    Journal of Translational Medicine.2022;[Epub]     CrossRef
  • The Potential Value of Gastric Histopathology for Predicting Colorectal Adenomatous Polyps Among the Chinese Population: A Retrospective Cross-Sectional Study
    Weiwei Li, Lin Zhang, Yuanming Jing, Yanfei Yang, Yulong Wang
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • The Dark Side of Iron: The Relationship between Iron, Inflammation and Gut Microbiota in Selected Diseases Associated with Iron Deficiency Anaemia—A Narrative Review
    Ida J. Malesza, Joanna Bartkowiak-Wieczorek, Jakub Winkler-Galicki, Aleksandra Nowicka, Dominika Dzięciołowska, Marta Błaszczyk, Paulina Gajniak, Karolina Słowińska, Leszek Niepolski, Jarosław Walkowiak, Edyta Mądry
    Nutrients.2022; 14(17): 3478.     CrossRef
  • Intratumoral microbiome and gastrointestinal cancers
    Shengnan Li, Qian Li, Wei Lu
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Bacteroides, butyric acid and t10,c12-CLA changes in colorectal adenomatous polyp patients
    Ciyan Chen, Min Niu, Junxi Pan, Na Du, Shumin Liu, Huanqin Li, Qiuyue He, Jian Mao, Yong Duan, Yan Du
    Gut Pathogens.2021;[Epub]     CrossRef
  • Dietary Rice Bran-Modified Human Gut Microbial Consortia Confers Protection against Colon Carcinogenesis Following Fecal Transfaunation
    Kristopher D. Parker, Akhilendra K. Maurya, Hend Ibrahim, Sangeeta Rao, Petronella R. Hove, Dileep Kumar, Rama Kant, Bupinder Raina, Rajesh Agarwal, Kristine A. Kuhn, Komal Raina, Elizabeth P. Ryan
    Biomedicines.2021; 9(2): 144.     CrossRef
  • Familial adenomatous polyposis and changes in the gut microbiota: New insights into colorectal cancer carcinogenesis
    Antonio Biondi, Francesco Basile, Marco Vacante
    World Journal of Gastrointestinal Oncology.2021; 13(6): 495.     CrossRef
  • Microbiome and gastrointestinal malignancies
    Ibrahim M Sayed, Haidi Karam-Allah Ramadan, Mohamed A El-Mokhtar, Lobna Abdel-Wahid
    Current Opinion in Physiology.2021; 22: 100451.     CrossRef
  • Effect of gut microbiome on minor complications after a colonoscopy
    Jae Hyun Kim, Youn Jung Choi, Hye Jung Kwon, Kyoungwon Jung, Sung Eun Kim, Won Moon, Moo In Park, Seun Ja Park
    Intestinal Research.2021; 19(3): 341.     CrossRef
  • Bacterial Extracellular Vesicles in Gastrointestinal Tract Cancer: An Unexplored Territory
    Sajeen Bahadur Amatya, Sonja Salmi, Veera Kainulainen, Peeter Karihtala, Justus Reunanen
    Cancers.2021; 13(21): 5450.     CrossRef
  • Dietary Patterns and Associated Microbiome Changes that Promote Oncogenesis
    Shakhzada Ibragimova, Revathy Ramachandran, Fahad R. Ali, Leonard Lipovich, Samuel B. Ho
    Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
  • High frequency of enterotoxigenic Bacteroides fragilis and Enterococcus faecalis in the paraffin-embedded tissues of Iranian colorectal cancer patients
    Nasibeh Khodaverdi, Habib Zeighami, Ahmad Jalilvand, Fakhri Haghi, Negar Hesami
    BMC Cancer.2021;[Epub]     CrossRef
  • Gut Microbiota Profiles in Early- and Late-Onset Colorectal Cancer: A Potential Diagnostic Biomarker in the Future
    Murdani Abdullah, Ninik Sukartini, Saskia Aziza Nursyirwan, Rabbinu Rangga Pribadi, Hasan Maulahela, Amanda Pitarini Utari, Virly Nanda Muzellina, Agustinus Wiraatmadja, Kaka Renaldi
    Digestion.2021; 102(6): 823.     CrossRef
  • The Role of the Gut Microbiome in Colorectal Cancer: Where Are We? Where Are We Going?
    Karina Wieczorska, Małgorzata Stolarek, Rafał Stec
    Clinical Colorectal Cancer.2020; 19(1): 5.     CrossRef
  • Fecal microbiota transplantation in disease therapy
    Hanna Antushevich
    Clinica Chimica Acta.2020; 503: 90.     CrossRef
  • Associations between gastric histopathology and the occurrence of colonic polyps
    A. Sonnenberg, K. O. Turner, R. M. Genta
    Colorectal Disease.2020; 22(7): 814.     CrossRef
  • Quercetin Suppresses AOM/DSS-Induced Colon Carcinogenesis through Its Anti-Inflammation Effects in Mice
    Rui Lin, Meiyu Piao, Yan Song, Chunyan Liu
    Journal of Immunology Research.2020; 2020: 1.     CrossRef
  • Intestinal Macrophages at the Crossroad between Diet, Inflammation, and Cancer
    Greta Caprara, Paola Allavena, Marco Erreni
    International Journal of Molecular Sciences.2020; 21(14): 4825.     CrossRef
  • Microbiome and colorectal cancer: Roles in carcinogenesis and clinical potential
    Ester Saus, Susana Iraola-Guzmán, Jesse R. Willis, Anna Brunet-Vega, Toni Gabaldón
    Molecular Aspects of Medicine.2019; 69: 93.     CrossRef
  • Fecal microbiota transplantation as a new therapy: from Clostridioides difficile infection to inflammatory bowel disease, irritable bowel syndrome, and colon cancer
    Thomas J Borody, Guy D Eslick, Robert L Clancy
    Current Opinion in Pharmacology.2019; 49: 43.     CrossRef
  • The association between fecal enterotoxigenic B. fragilis with colorectal cancer
    Fakhri Haghi, Elshan Goli, Bahman Mirzaei, Habib Zeighami
    BMC Cancer.2019;[Epub]     CrossRef
  • Who is who in oral cancer?
    Wei-long Zhang, Sha-sha Wang, Hao-fan Wang, Ya-Jie Tang, Ya-ling Tang, Xin-hua Liang
    Experimental Cell Research.2019; 384(2): 111634.     CrossRef
  • Melanoma-Bearing Libechov Minipig (MeLiM): The Unique Swine Model of Hereditary Metastatic Melanoma
    Vratislav Horak, Anna Palanova, Jana Cizkova, Veronika Miltrova, Petr Vodicka, Helena Kupcova Skalnikova
    Genes.2019; 10(11): 915.     CrossRef
  • Non-alcoholic fatty liver disease and colorectal cancer: A marker of risk or common causation?
    Niki Katsiki, Dimitri P. Mikhailidis, Christos Mantzoros
    Metabolism.2018; 87: A10.     CrossRef
  • Echinococcus granulosus Infection Results in an Increase in Eisenbergiella and Parabacteroides Genera in the Gut of Mice
    Jianling Bao, Huajun Zheng, Yuezhu Wang, Xueting Zheng, Li He, Wenjing Qi, Tian Wang, Baoping Guo, Gang Guo, Zhaoxia Zhang, Wenbao Zhang, Jun Li, Donald P. McManus
    Frontiers in Microbiology.2018;[Epub]     CrossRef
  • Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis
    Linda Chia-Hui Yu
    Journal of Biomedical Science.2018;[Epub]     CrossRef
  • 8,394 View
  • 231 Download
  • 43 Web of Science
  • 41 Crossref
Close layer
Colorectal neoplasia
Serrated neoplasia pathway as an alternative route of colorectal cancer carcinogenesis
Soon Young Kim, Tae Il Kim
Intest Res 2018;16(3):358-365.   Published online July 27, 2018
DOI: https://doi.org/10.5217/ir.2018.16.3.358
AbstractAbstract PDFPubReaderePub

In the past two decades, besides conventional adenoma pathway, a subset of colonic lesions, including hyperplastic polyps, sessile serrated adenoma/polyps, and traditional serrated adenomas have been suggested as precancerous lesions via the alternative serrated neoplasia pathway. Major molecular alterations of sessile serrated neoplasia include BRAF mutation, high CpG island methylator phenotype, and escape of cellular senescence and progression via methylation of tumor suppressor genes or mismatch repair genes. With increasing information of the morphologic and molecular features of serrated lesions, one major challenge is how to reflect this knowledge in clinical practice, such as pathologic and endoscopic diagnosis, and guidelines for treatment and surveillance.

Citations

Citations to this article as recorded by  
  • Impact of Clinical and Endoscopic Features on the Development of Metachronous Colorectal Advanced Serrated Lesions
    Carol Rouphael, Jessica El Halabi, James Bena, John McMichael, Carol A. Burke
    Clinical Gastroenterology and Hepatology.2024; 22(5): 1117.     CrossRef
  • Serum DNA methylome of the colorectal cancer serrated pathway enables non‐invasive detection
    María Gallardo‐Gómez, Lara Costas‐Ríos, Carlos A. Garcia‐Prieto, Lara Álvarez‐Rodríguez, Luis Bujanda, Maialen Barrero, Antoni Castells, Francesc Balaguer, Rodrigo Jover, Manel Esteller, Antoni Tardío Baiges, Joaquín González‐Carreró Fojón, Joaquín Cubiel
    Molecular Oncology.2024;[Epub]     CrossRef
  • Different modifiable risk factors for the development of non-advanced adenoma, advanced adenomatous lesion, and sessile serrated lesions, on screening colonoscopy
    A. Reum Choe, Eun Mi Song, Heeju Seo, Hyunju Kim, Gyuri Kim, Sojin Kim, Ju Ran Byeon, Yehyun Park, Chung Hyun Tae, Ki-Nam Shim, Sung-Ae Jung
    Scientific Reports.2024;[Epub]     CrossRef
  • Accuracy and Inter-observer Agreement Among Endoscopists for Visual Identification of Colorectal Polyps Using Endoscopy Images
    Thi Khuc, Amol Agarwal, Feng Li, Sergey Kantsevoy, Bryan Curtin, Matilda Hagan, Mary Harris, Anurag Maheshwari, Amit Raina, Elinor Zhou, Paul Thuluvath
    Digestive Diseases and Sciences.2023; 68(2): 616.     CrossRef
  • Sessile serrated lesion detection rates continue to increase: 2008–2020
    Nicholas Edwardson, Prajakta Adsul, Zorisadday Gonzalez, V. Shane Pankratz, Gulshan Parasher, Kevin English, Shiraz Mishra
    Endoscopy International Open.2023; 11(01): E107.     CrossRef
  • Escape from oncogene-induced senescence is controlled by POU2F2 and memorized by chromatin scars
    Ricardo Iván Martínez-Zamudio, Alketa Stefa, José Américo Nabuco Leva Ferreira Freitas, Themistoklis Vasilopoulos, Mark Simpson, Gregory Doré, Pierre-François Roux, Mark A. Galan, Ravi J. Chokshi, Oliver Bischof, Utz Herbig
    Cell Genomics.2023; 3(4): 100293.     CrossRef
  • Summary and comparison of recently updated post-polypectomy surveillance guidelines
    Yoon Suk Jung
    Intestinal Research.2023; 21(4): 443.     CrossRef
  • Serrated lesions of colon
    Bhanushree C S
    Indian Journal of Pathology and Oncology.2023; 10(4): 332.     CrossRef
  • Serrated Polyps and the Risk of Metachronous Colorectal Advanced Neoplasia: A Systematic Review and Meta-Analysis
    Yoon Suk Jung, Jung Ho Park, Chan Hyuk Park
    Clinical Gastroenterology and Hepatology.2022; 20(1): 31.     CrossRef
  • Risk of developing metachronous colorectal neoplasia after the resection of proximal versus distal adenomas
    Yoon Suk Jung, Nam Hee Kim, Youngwoo Kim, Dong Il Park
    Digestive and Liver Disease.2022; 54(4): 537.     CrossRef
  • Diabetes mellitus in relation to colorectal tumor molecular subtypes: A pooled analysis of more than 9000 cases
    Sophia Harlid, Bethany Van Guelpen, Conghui Qu, Björn Gylling, Elom K. Aglago, Efrat L. Amitay, Hermann Brenner, Daniel D. Buchanan, Peter T. Campbell, Yin Cao, Andrew T. Chan, Jenny Chang‐Claude, David A. Drew, Jane C. Figueiredo, Amy J. French, Steven G
    International Journal of Cancer.2022; 151(3): 348.     CrossRef
  • Insulin levels are associated with risk of colon adenoma and not nonadenomatous polyps: A retrospective, hospital-based study
    Hwang Sik Shin, Yong Jin Cho
    Medicine.2022; 101(34): e30200.     CrossRef
  • Left-sided colorectal cancer distinct in indigenous African patients compared to other ethnic groups in South Africa
    Michelle McCabe, Clement Penny, Pumza Magangane, Sheefa Mirza, Yvonne Perner
    BMC Cancer.2022;[Epub]     CrossRef
  • Asymmetric crypt fission in sessile serrated lesions
    Carlos A Rubio, Peter T Schmidt
    Journal of Clinical Pathology.2021; 74(11): 712.     CrossRef
  • EGFR and BRAF mutations in inverted sinonasal papilloma — a more complex landscape?
    Sarah Zonnur, Andreas Erbersdobler, Björn Schneider
    Virchows Archiv.2021; 478(5): 915.     CrossRef
  • Postgastrectomy gastric cancer patients are at high risk for colorectal neoplasia: a case control study
    Tae-Geun Gweon, Kyu-Tae Yoon, Chang Hyun Kim, Jin-Jo Kim
    Intestinal Research.2021; 19(2): 239.     CrossRef
  • Sessile serrated adenoma/polyp detection rate of water exchange, Endocuff, and cap colonoscopy: A network meta‐analysis
    Paul P Shao, Changhan R Shao, Tahmineh Romero, Felix W Leung
    Journal of Gastroenterology and Hepatology.2021; 36(12): 3268.     CrossRef
  • Tribbles Gene Expression Profiles in Colorectal Cancer
    Mónica T. Fernandes, Victor Yassuda, José Bragança, Wolfgang Link, Bibiana I. Ferreira, Ana Luísa De Sousa-Coelho
    Gastrointestinal Disorders.2021; 3(4): 218.     CrossRef
  • Imaging predictors of BRAF mutation in colorectal cancer
    Kulyada Eurboonyanun, Rita Maria Lahoud, Hamed Kordbacheh, Ali Pourvaziri, Julaluck Promsorn, Payia Chadbunchachai, Aileen O’Shea, Isha D. Atre, Mukesh Harisinghani
    Abdominal Radiology.2020; 45(8): 2336.     CrossRef
  • Glimmers of Hope—New Strategies for Overcoming Treatment Resistance in Patients with BRAF V600E-mutated Metastatic Colorectal Cancer
    Samantha A Armstrong, Rita Malley, Benjamin A Weinberg
    Oncology & Hematology Review (US).2020; 16(1): 31.     CrossRef
  • Association Between Cigarette Smoking and Alcohol Consumption and Sessile Serrated Polyps in Subjects 30 to 49 Years Old
    Ji Young Lee, Hye-Sook Chang, Tae Hyup Kim, Eun Ju Chung, Hye Won Park, Jong-Soo Lee, Sun Mi Lee, Dong-Hoon Yang, Jaewon Choe, Jeong-Sik Byeon
    Clinical Gastroenterology and Hepatology.2019; 17(8): 1551.     CrossRef
  • Risk factors of traditional serrated adenoma and clinicopathologic characteristics of synchronous conventional adenoma
    Jeongseok Kim, Ji Young Lee, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, Seung-Jae Myung, Suk-Kyun Yang, Ja Eun Koo, Hyo Jeong Lee, Jaewon Choe, Jeong-Sik Byeon
    Gastrointestinal Endoscopy.2019; 90(4): 636.     CrossRef
  • Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population
    L.J.W. Bosch, V. Melotte, S. Mongera, K.L.J. Daenen, V.M.H. Coupé, S.T. van Turenhout, E.M. Stoop, T.R. de Wijkerslooth, C.J.J. Mulder, C. Rausch, E.J. Kuipers, E. Dekker, M.J. Domanico, G.P. Lidgard, B.M. Berger, M. van Engeland, B. Carvalho, G.A. Meijer
    American Journal of Gastroenterology.2019; 114(12): 1909.     CrossRef
  • 8,396 View
  • 205 Download
  • 23 Web of Science
  • 23 Crossref
Close layer
Reviews
IBD
What's app? Electronic health technology in inflammatory bowel disease
Alissa Walsh, Simon Travis
Intest Res 2018;16(3):366-373.   Published online July 27, 2018
DOI: https://doi.org/10.5217/ir.2018.16.3.366
AbstractAbstract PDFPubReaderePub

Electronic health (eHealth) data collection is increasingly used in many chronic illnesses, to track pattern of disease. eHealth systems have the potential to revolutionize care. Inflammatory bowel disease (IBD) is a paradigm for such an approach: this is a chronic disease that usually affects young and technologically literate patient population, who are motivated to be involved in their own care. A range of eHealth technologies are available for IBD. This review considers the strengths and weaknesses of 7 platforms that focus on patient-provider interaction. These have been developed in Denmark, United States, the Netherlands, and the United Kingdom, demonstrating an international interest in this form of technology and interaction. Not only do these technologies aim to improve care but they also have the potential to collect large amounts of information. Information includes demographics and patient reported outcomes (symptoms, quality of life), quality of care (steroid use, among other metrics) and outcomes such as hospitalization. These data could inform quality improvement programmes to improve their focus. eHealth technology is also open to machine learning to analyze large data sets, through which personalized algorithms may be developed.

Citations

Citations to this article as recorded by  
  • Validation of the IBD-Control Questionnaire across different sociodemographic and clinical subgroups: secondary analysis of a nationwide electronic survey
    Gerum G Gebeyehu, Frederick Taylor, Liz Dobson, J R Fraser Cummings, Stuart Bloom, Nicholas A Kennedy, Paul Christiansen, Keith Bodger
    Journal of Crohn's and Colitis.2024; 18(2): 275.     CrossRef
  • Investigating Patient Perspectives on Using eHealth Technologies for the Self-Management of Inflammatory Bowel Disease: Mixed Methods Study
    Sander Hermsen, Danielle Tump, Eva Wentink, Marjolijn Duijvestein
    Journal of Medical Internet Research.2024; 26: e53512.     CrossRef
  • How can pharmacists better support patients with chronic diseases? The patient perspective
    Lakesha Butler, Steven Zona, Aarti A. Patel, Christine Brittle, Lisa Shea
    Journal of the American Pharmacists Association.2023; 63(6): 1776.     CrossRef
  • Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives
    Konstantinos Papamichael, Waqqas Afif, David Drobne, Marla C Dubinsky, Marc Ferrante, Peter M Irving, Nikolaos Kamperidis, Taku Kobayashi, Paulo G Kotze, Jo Lambert, Nurulamin M Noor, Xavier Roblin, Giulia Roda, Niels Vande Casteele, Andres J Yarur, Naila
    The Lancet Gastroenterology & Hepatology.2022; 7(2): 171.     CrossRef
  • Telemedicine based on patient-reported outcomes in management of patients with inflammatory bowel disease in a real-life setting – a before and after cohort study
    Charlotte W. Appel, Sarah Christine Pedersen, Amalie Søgaard Nielsen, Birgit Furstrand Larsen
    Scandinavian Journal of Gastroenterology.2022; 57(7): 825.     CrossRef
  • Readiness, acceptance and use of digital patient reported outcome in an outpatient clinic
    Amalie Søgaard Nielsen, Lisa Hanna, Birgit Furstrand Larsen, Charlotte W Appel, Richard H Osborne, Lars Kayser
    Health Informatics Journal.2022; 28(2): 146045822211060.     CrossRef
  • The International Association of Dental Traumatology ToothSOS mobile app: A 2‐year report
    Anahat Khehra, Nestor Cohenca, Zafer C. Cehreli, Liran Levin
    Dental Traumatology.2021; 37(1): 145.     CrossRef
  • Telehealth and mobile health interventions in adults with inflammatory bowel disease: A mixed‐methods systematic review
    Suja P. Davis, Megan Suzanne Hardin Ross, Reuben Adatorwovor, Holly Wei
    Research in Nursing & Health.2021; 44(1): 155.     CrossRef
  • Real-life pilot study on the impact of the telemedicine platform EasyMICI–MaMICI® on quality of life and quality of care in patients with inflammatory bowel disease
    Guillaume Bonnaud, Audrey Haennig, Romain Altwegg, Bénédicte Caron, Lucile Boivineau, Camille Zallot, Cyrielle Gilleta de Saint-Joseph, Jacques Moreau, Florent Gonzalez, Didier Reynaud, Patrick Faure, Philippe Aygalenq, Jean Marc Combis, Laurent Peyrin-Bi
    Scandinavian Journal of Gastroenterology.2021; 56(5): 530.     CrossRef
  • Patient Reported Outcomes in Chronic Inflammatory Diseases: Current State, Limitations and Perspectives
    Florian Tran, Jan Henrik Schirmer, Ilka Ratjen, Wolfgang Lieb, Philip Helliwell, Johan Burisch, Juliane Schulz, Florian Schrinner, Charlot Jaeckel, Ulf Müller-Ladner, Stefan Schreiber, Bimba F. Hoyer
    Frontiers in Immunology.2021;[Epub]     CrossRef
  • Researching Interventions to Improve Medication Adherence in Ulcerative Colitis Patients
    Mila Palma Pacheco, Flora Maria Lorenzo Fortes, Raquel Rocha dos Santos, Genoile Oliveira Santana Silva
    Journal of Coloproctology.2021; 41(01): 096.     CrossRef
  • Mobile app requirements for patients with rare liver diseases: A single center survey for the ERN RARE-LIVER‬‬‬
    Darius F. Rüther, Marcial Sebode, Ansgar W. Lohse, Sarah Wernicke, Erwin Böttinger, Christian Casar, Felix Braun, Christoph Schramm
    Clinics and Research in Hepatology and Gastroenterology.2021; 45(6): 101760.     CrossRef
  • E‐Health and remote management of patients with inflammatory bowel disease: lessons from Denmark in a time of need
    Dorit V. Ankersen, Savannah Noack, Pia Munkholm, Miles P. Sparrow
    Internal Medicine Journal.2021; 51(8): 1207.     CrossRef
  • Patient Experience and Satisfaction with an e-Health Care Management Application for Inflammatory Bowel Diseases
    Aria Zand, Audrey Nguyen, Courtney Reynolds, Ariela Khandadash, Eric Esrailian, Daniel Hommes
    International Journal of Environmental Research and Public Health.2021; 18(22): 11747.     CrossRef
  • Developments and challenges of e-health strategies for people with inflammatory bowel disease
    Pearl Avery
    British Journal of Healthcare Management.2020; 26(3): 73.     CrossRef
  • Development and feasibility of a telemonitoring tool with full integration in the electronic medical record: a proof of concept study for patients with inflammatory bowel disease in remission on biological therapy
    Sofie Coenen, Egon Nijns, Ellen Weyts, Patricia Geens, Bart Van den Bosch, Séverine Vermeire, Marc Ferrante, Kris Vanhaecht, Gert Van Assche
    Scandinavian Journal of Gastroenterology.2020; 55(3): 287.     CrossRef
  • Organisational changes and challenges for inflammatory bowel disease services in the UK during the COVID-19 pandemic
    Nicholas A Kennedy, Richard Hansen, Lisa Younge, Joel Mawdsley, R Mark Beattie, Shahida Din, Christopher A Lamb, Philip J Smith, Christian Selinger, Jimmy Limdi, Tariq H Iqbal, Alan Lobo, Rachel Cooney, Oliver Brain, Daniel R Gaya, Charles Murray, Richard
    Frontline Gastroenterology.2020; 11(5): 343.     CrossRef
  • Crohn’s Colitis Care (CCCare): bespoke cloud-based clinical management software for inflammatory bowel disease
    Krupa Krishnaprasad, Alissa Walsh, Jakob Begun, Sally Bell, David Carter, Rachel Grafton, Alexandra Sechi, Karen Sewell, Anna McMahon, Susan Connor, Graham Radford-Smith, Jane M. Andrews
    Scandinavian Journal of Gastroenterology.2020; 55(12): 1419.     CrossRef
  • Exploring the Challenges of Implementing a Web-Based Telemonitoring Strategy for Teenagers With Inflammatory Bowel Disease: Empirical Case Study
    Alie Dijkstra, Anke Heida, Patrick Ferry van Rheenen
    Journal of Medical Internet Research.2019; 21(3): e11761.     CrossRef
  • Digital Health Apps in the Clinical Care of Inflammatory Bowel Disease: Scoping Review
    Andrew Lukas Yin, David Hachuel, John P Pollak, Ellen J Scherl, Deborah Estrin
    Journal of Medical Internet Research.2019; 21(8): e14630.     CrossRef
  • 8,436 View
  • 142 Download
  • 20 Web of Science
  • 20 Crossref
Close layer
IBD
Delineating inflammatory bowel disease through transcriptomic studies: current review of progress and evidence
Seow-Neng Chan, Eden Ngah Den Low, Raja Affendi Raja Ali, Norfilza Mohd Mokhtar
Intest Res 2018;16(3):374-383.   Published online July 27, 2018
DOI: https://doi.org/10.5217/ir.2018.16.3.374
AbstractAbstract PDFPubReaderePub

Inflammatory bowel disease (IBD), which comprises of Crohn's disease and ulcerative colitis, is an idiopathic relapsing and remitting disease in which the interplay of different environment, microbial, immunological and genetic factors that attribute to the progression of the disease. Numerous studies have been conducted in multiple aspects including clinical, endoscopy and histopathology for the diagnostics and treatment of IBD. However, the molecular mechanism underlying the aetiology and pathogenesis of IBD is still poorly understood. This review tries to critically assess the scientific evidence at the transcriptomic level as it would help in the discovery of RNA molecules in tissues or serum between the healthy and diseased or different IBD subtypes. These molecular signatures could potentially serve as a reliable diagnostic or prognostic biomarker. Researchers have also embarked on the study of transcriptome to be utilized in targeted therapy. We focus on the evaluation and discussion related to the publications reporting the different approaches and techniques used in investigating the transcriptomic changes in IBD with the intention to offer new perspectives to the landscape of the disease.

Citations

Citations to this article as recorded by  
  • Composition of the colon microbiota in the individuals with inflammatory bowel disease and colon cancer
    Ceren Acar, Sibel Kucukyildirim Celik, H. Ozgur Ozdemirel, Beril Erdem Tuncdemir, Saadet Alan, Hatice Mergen
    Folia Microbiologica.2024; 69(2): 333.     CrossRef
  • Cytokine Signatures in Inflamed Mucosa of IBD Patients: State-of-the-Art
    Milena Peruhova, Dimitrina Miteva, Maria Kokudeva, Sonya Banova, Tsvetelina Velikova
    Gastroenterology Insights.2024; 15(2): 471.     CrossRef
  • CrohnDB: A Web Database for Expression Profiling of Protein-Coding and Long Non-Coding RNA Genes in Crohn Disease
    Rebecca Distefano, Mirolyuba Ilieva, Jens Hedelund Madsen, Shizuka Uchida
    Computation.2023; 11(6): 105.     CrossRef
  • Genetic and Epigenetic Etiology of Inflammatory Bowel Disease: An Update
    Sara Jarmakiewicz-Czaja, Magdalena Zielińska, Aneta Sokal, Rafał Filip
    Genes.2022; 13(12): 2388.     CrossRef
  • Biological impact of mutually exclusive exon switching
    Su Datt Lam, M. Madan Babu, Jonathan Lees, Christine A. Orengo, Marco Punta
    PLOS Computational Biology.2021; 17(3): e1008708.     CrossRef
  • Relating the transcriptome and microbiome by paired terminal ileal Crohn disease
    Chenwen Cai, Sibo Zhu, Jinlu Tong, Tianrong Wang, Qi Feng, Yuqi Qiao, Jun Shen
    iScience.2021; 24(6): 102516.     CrossRef
  • Meta-Analysis of Expression Profiling Data Indicates Need for Combinatorial Biomarkers in Pediatric Ulcerative Colitis
    Xinxiu Li, Eun Jung Lee, Danuta R. Gawel, Sandra Lilja, Samuel Schäfer, Huan Zhang, Mikael Benson
    Journal of Immunology Research.2020; 2020: 1.     CrossRef
  • Inherent Immune Cell Variation Within Colonic Segments Presents Challenges for Clinical Trial Design
    Christopher J Tyler, Mauricio Guzman, Luke R Lundborg, Shaila Yeasmin, Tamara Perez-Jeldres, Andres Yarur, Brian Behm, Parambir S Dulai, Derek Patel, Giorgos Bamias, Jesús Rivera-Nieves
    Journal of Crohn's and Colitis.2020; 14(10): 1364.     CrossRef
  • TL1A primed dendritic cells activation exacerbated chronic murine colitis
    Fei Han, Jia Song, Wenxiu Jia, Mingyue Yang, Dong Wang, Hong Zhang, David Q. Shih, Stephan R. Targan, Xiaolan Zhang
    Life Sciences.2020; 262: 118220.     CrossRef
  • Colonic Mucosal Transcriptomic Changes in Patients with Long-Duration Ulcerative Colitis Revealed Colitis-Associated Cancer Pathways
    Eden Ngah Den Low, Norfilza Mohd Mokhtar, Zhiqin Wong, Raja Affendi Raja Ali
    Journal of Crohn's and Colitis.2019; 13(6): 755.     CrossRef
  • A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia
    Norfilza Mohd Mokhtar, Khairul Najmi Muhammad Nawawi, Jaarvis Verasingam, Wong Zhiqin, Ismail Sagap, Zairul Azwan Mohd Azman, Luqman Mazlan, Hamzaini Abdul Hamid, Nur Yazmin Yaacob, Isa Mohamed Rose, Eden Low Ngah Den, Mah Suit Wan, Raja Affendi Raja Ali
    BMC Public Health.2019;[Epub]     CrossRef
  • 9,796 View
  • 124 Download
  • 11 Web of Science
  • 11 Crossref
Close layer
Original Articles
IBD
β-(1,3)-Glucan derived from Candida albicans induces inflammatory cytokines from macrophages and lamina propria mononuclear cells derived from patients with Crohn's disease
Kiyoto Mori, Makoto Naganuma, Shinta Mizuno, Hiroaki Suzuki, Mina T. Kitazume, Katsuyoshi Shimamura, Sayako Chiba, Akira Sugita, Katsuyoshi Matsuoka, Tadakazu Hisamatsu, Takanori Kanai
Intest Res 2018;16(3):384-392.   Published online July 27, 2018
DOI: https://doi.org/10.5217/ir.2018.16.3.384
AbstractAbstract PDFSupplementary MaterialPubReaderePub
<b>Background/Aims</b><br/>

Recent research has highlighted the importance of interactions between commensal fungi and intestinal inflammation. However, there are few studies investigating whether commensal fungi contribute to inflammation in patients with Crohn's disease (CD). The aim of this study is to investigate reveal interactions between commensal fungi and host immune cells in CD.

Methods

CD14-positive monocytes were isolated from peripheral blood mononuclear cells from healthy human volunteers and then differentiated in the presence of macrophage colony-stimulating factor (M-CSF) (referred to as M-macrophages, M-Mϕs) or M-CSF and interferon-γ (IFN-γ) (referred to as M-gamma macrophages, Mγ-Mϕs). Cytokine production by these in vitro differentiated macrophages in response to β-(1,3)-glucan was analyzed by flow cytometry. Expression of Dectin-1 was examined using flow cytometry, western blotting, and quantitative reverse transcription-polymerase chain reaction. Cytokine production by in vitro differentiated macrophages in response to β-(1,3)-glucan was measured in the presence of an anti-Dectin-1 receptor antagonist, anti-Syr, or an anti-Fas-1 antibody. Cytokine production by lamina propria mononuclear cells (LPMCs) derived from CD patients in response to β-(1,3)-glucan was also analyzed.

Results

Mγ-Mϕs produced a large amount of tumor necrosis factor-α (TNF-α) and interleukin-6 in response to β-(1,3)-glucan. Dectin-1 expression was significantly higher in Mγ-Mϕs than in M-Mϕs. The increase in TNF-α production by Mγ-Mϕs stimulated with glucan was reversed by blocking Dectin-1, Syr or Fas-1. LPMCs derived from CD patients stimulated with β-(1,3)-glucan produced significantly higher amount of TNF-α than LPMCs derived from UC patients.

Conclusions

These results suggest that commensal fungal microbiota may contribute to the pathogenesis of CD by inducing macrophages-derived pro-inflammatory cytokines.

Citations

Citations to this article as recorded by  
  • Heat Shock Protein SSA1 Enriched in Hypoxic Secretome of Candida albicans Exerts an Immunomodulatory Effect via Regulating Macrophage Function
    Wei Teng, Phawinee Subsomwong, Kouji Narita, Akio Nakane, Krisana Asano
    Cells.2024; 13(2): 127.     CrossRef
  • Antifungal immunity mediated by C-type lectin receptors may be a novel target in immunotherapy for urothelial bladder cancer
    Tianhang Li, Tianyao Liu, Zihan Zhao, Yuchen Pan, Xinyan Xu, Yulin Zhang, Shoubin Zhan, Shengkai Zhou, Wenjie Zhu, Hongqian Guo, Rong Yang
    Frontiers in Immunology.2022;[Epub]     CrossRef
  • Serum 1,3-beta-D-glucan as a noninvasive test to predict histologic activity in patients with inflammatory bowel disease
    Katia Farias e Silva, Hayandra F Nanini, Cynthia Machado Cascabulho, Siane L B Rosas, Patricia T Santana, Antonio José de V Carneiro, Elias Anaissie, Marcio Nucci, Heitor Siffert Pereira de Souza
    World Journal of Gastroenterology.2021; 27(9): 866.     CrossRef
  • Effects of Medicinal Fungi-Derived β-Glucan on Tumor Progression
    Vaclav Vetvicka, Tamara V. Teplyakova, Alexandra B. Shintyapina, Tatiana A. Korolenko
    Journal of Fungi.2021; 7(4): 250.     CrossRef
  • The Role of IL-17-Producing Cells in Cutaneous Fungal Infections
    Yu Sawada, Ayako Setoyama, Yumiko Sakuragi, Natsuko Saito-Sasaki, Haruna Yoshioka, Motonobu Nakamura
    International Journal of Molecular Sciences.2021; 22(11): 5794.     CrossRef
  • 9,592 View
  • 118 Download
  • 5 Web of Science
  • 5 Crossref
Close layer
IBD
Immunohistochemical differentiation between chronic enteropathy associated with SLCO2A1 gene and other inflammatory bowel diseases
Satoko Yamaguchi, Shunichi Yanai, Shotaro Nakamura, Keisuke Kawasaki, Makoto Eizuka, Noriyuki Uesugi, Tamotsu Sugai, Junji Umeno, Motohiro Esaki, Takayuki Matsumoto
Intest Res 2018;16(3):393-399.   Published online July 27, 2018
DOI: https://doi.org/10.5217/ir.2018.16.3.393
AbstractAbstract PDFPubReaderePub
<b>Background/Aims</b><br/>

We recently identified recessive mutations in the solute carrier organic anion transporter family member 2A1 gene (SLCO2A1) as causative variants of chronic enteropathy associated with SLCO2A1 (CEAS). The aim of this study was to evaluate SLCO2A1 protein expression in the intestinal tissues of patients with CEAS, intestinal Behçet's disease (BD), simple ulcer (SU), and Crohn's disease (CD).

Methods

Immunohistochemical staining using a polyclonal anti-SLCO2A1 antibody was performed on the resected intestinal specimens from 13 cases of CD, 9 cases of intestinal BD/SU, and 3 cases of CEAS. The extent of SLCO2A1 expression was determined by counting positively-staining vascular endothelial cells and scored as 0 (no cells), 1 (1%–30% cells), 2 (31%–60%), or 3 (>60%). The intensity of SLCO2A1 expression was scored either as 0 (negative), 1 (intermediate), or 2 (strong). The extent score and intensity score were summed for the final score of 0, 2, 3, 4, or 5.

Results

SLCO2A1 protein expression was observed in 1 of 3 cases of CEAS (33%), all 13 cases of CD (100%), and all 9 cases of BD/SU (100%). The mean final expression scores of CEAS, CD, and BD/SU were 1.6 (range, 0–5), 4.8 (range, 4–5), and 4.3 (range, 4–5), respectively. The final expression score in CEAS was significantly lower than in CD (P=0.03).

Conclusions

Immunohistochemical staining of the SLCO2A1 protein is considered useful to distinguish CEAS from other inflammatory bowel diseases.

Citations

Citations to this article as recorded by  
  • First case report of dichorionic diamniotic twins with chronic enteropathy associated with the SLCO2A1 gene
    Ryutaro Saura, Shin-ichiro Hagiwara, Keinosuke Hizuka, Nobuhiko Okamoto, Yuri Etani
    Clinical Journal of Gastroenterology.2024; 17(2): 240.     CrossRef
  • Characteristics of chronic enteropathy associated with SLCO2A1 gene (CEAS) in children, a unique type of monogenic very early-onset inflammatory bowel disease
    Jin Gyu Lim, Jae Sung Ko, Jung Min Ko, Hyun Young Kim, Man Jin Kim, Moon Woo Seong, Young Hun Choi, Gyeong Hoon Kang, Jaemoon Koh, Jin Soo Moon
    BMC Pediatrics.2024;[Epub]     CrossRef
  • Clinical and genetic characteristics of Chinese patients diagnosed with chronic enteropathy associated with SLCO2A1 gene
    Qing Shang, Yimin Dai, Jingyi Huang, Wei Liu, Weixun Zhou, Yaping Liu, Hong Yang, Qiang Wang, Yue Li
    Orphanet Journal of Rare Diseases.2024;[Epub]     CrossRef
  • Capsule Endoscopy for the Diagnosis of Suspected Small Bowel Bleeding
    P. P. Polyakov, A. Ya. Alimetov, A. V. Onopriev, A. V. Avakimyan, A. Kh. Kade, S. A. Zanin, E. S. Zanina, Z. S. Popov, A. I. Trofimenko, Z. T. Jndoyan, A. A. Avagimyan
    Innovative Medicine of Kuban.2023; (3): 121.     CrossRef
  • Attenuated Expression of SLCO2A1 Caused by DNA Methylation in Pediatric Inflammatory Bowel Disease
    Natsuki Ito, Takahiro Kudo, Hidetaka Eguchi, Keisuke Jimbo, Atsushi Furuhata, Toshiaki Okuno, Ichiro Takeuchi, Katsuhiro Arai, Takashi Ishige, Yasushi Okazaki, Toshiaki Shimizu
    Inflammatory Bowel Diseases.2023; 29(12): 1920.     CrossRef
  • Updates on the diagnosis and management of cryptogenic multifocal ulcerative stenosing enteropathy (CMUSE) and non-steroidal enteropathy
    Tom G. Moreels, Ayaskanta Singh
    Best Practice & Research Clinical Gastroenterology.2023; 64-65: 101847.     CrossRef
  • Chronic Enteropathy Associated with Solute Carrier Organic Anion Transporter Family, Member 2A1 (SLCO2A1) with Positive Immunohistochemistry for SLCO2A1 Protein
    Chizuru Ariake, Naoki Hosoe, Hinako Sakurai, Anna Tojo, Yukie Hayashi, Kenji JL Limpias Kamiya, Tomohisa Sujino, Kaoru Takabayashi, Kenjiro Kosaki, Satowa Seki, Tadakazu Hisamatsu, Haruhiko Ogata, Takanori Kanai
    Internal Medicine.2022; 61(17): 2607.     CrossRef
  • Epithelial Abnormalities in the Small Intestine of Zambian Children With Stunting
    Chola Mulenga, Sanja Sviben, Kanta Chandwe, Beatrice Amadi, Violet Kayamba, James A. J. Fitzpatrick, Victor Mudenda, Paul Kelly
    Frontiers in Medicine.2022;[Epub]     CrossRef
  • Functional analysis of mutant SLCO2A1 transporters found in patients with chronic enteropathy associated with SLCO2A1
    Satowa Seki, Gen Tanaka, Toru Kimura, Mari Hayashida, Jun Miyoshi, Minoru Matsuura, Hiroyuki Sakurai, Tadakazu Hisamatsu
    Journal of Gastroenterology and Hepatology.2022; 37(9): 1776.     CrossRef
  • Clinical and Genetic Characteristics of Korean Patients Diagnosed with Chronic Enteropathy Associated with SLCO2A1 Gene: A KASID Multicenter Study
    Hee Seung Hong, Jiwon Baek, Jae Chul Park, Ho-Su Lee, Dohoon Park, A-Ran Yoon, Soo Jung Park, Sung Noh Hong, Seong-Joon Koh, Chang Kyun Lee, Bo-In Lee, Sung Wook Hwang, Sang Hyoung Park, Seung-Jae Myung, Suk-Kyun Yang, Kyuyoung Song, Byong Duk Ye
    Gut and Liver.2022; 16(6): 942.     CrossRef
  • Recent advances in studies of SLCO2A1 as a key regulator of the delivery of prostaglandins to their sites of action
    Takeo Nakanishi, Yoshinobu Nakamura, Junji Umeno
    Pharmacology & Therapeutics.2021; 223: 107803.     CrossRef
  • Meta-Analysis-Assisted Detection of Gravity-Sensitive Genes in Human Vascular Endothelial Cells
    Yin Liang, Mengxue Wang, Yun Liu, Chen Wang, Ken Takahashi, Keiji Naruse
    Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
  • Chronic Nonspecific Multiple Ulcers of the Small Intestine / Chronic Enteropathy Associated with SLCO2A1 Gene (CEAS)
    Junji Umeno, Yuta Fuyuno, Yuichi Matsuno, Takehiro Torisu
    Nippon Daicho Komonbyo Gakkai Zasshi.2021; 74(10): 581.     CrossRef
  • Retrospective study of the differential diagnosis between cryptogenic multifocal ulcerous stenosing enteritis and small bowel Crohn’s disease
    Dan Chen, Wei Liu, Weixun Zhou, Weiyang Zheng, Dong Wu, Jiaming Qian
    BMC Gastroenterology.2020;[Epub]     CrossRef
  • Chronic Enteropathy Associated with SLCO2A1 with Pachydermoperiostosis
    Yoshikazu Tsuzuki, Ryutaro Aoyagi, Kazuya Miyaguchi, Keigo Ashitani, Hideki Ohgo, Minoru Yamaoka, Keisuke Ishizawa, Hidekazu Kayano, Tadakazu Hisamatsu, Junji Umeno, Naoki Hosoe, Takayuki Matsumoto, Hidetomo Nakamoto, Hiroyuki Imaeda
    Internal Medicine.2020; 59(24): 3147.     CrossRef
  • Small bowel ulcers
    Martin Keuchel, Niehls Kurniawan, Peter Baltes
    Current Opinion in Gastroenterology.2019; 35(3): 213.     CrossRef
  • Measurement of prostaglandin metabolites is useful in diagnosis of small bowel ulcerations
    Yuichi Matsuno, Junji Umeno, Motohiro Esaki, Yoichiro Hirakawa, Yuta Fuyuno, Yasuharu Okamoto, Atsushi Hirano, Shigeyoshi Yasukawa, Fumihito Hirai, Toshiyuki Matsui, Shuhei Hosomi, Kenji Watanabe, Naoki Hosoe, Haruhiko Ogata, Tadakazu Hisamatsu, Shunichi
    World Journal of Gastroenterology.2019; 25(14): 1753.     CrossRef
  • Distinction between Chronic Enteropathy Associated with the SLCO2A1 Gene and Crohn's Disease
    Shunichi Yanai, Satoko Yamaguchi, Shotaro Nakamura, Keisuke Kawasaki, Yosuke Toya, Noriyuki Yamada, Makoto Eizuka, Noriyuki Uesugi, Junji Umeno, Motohiro Esaki, Eiko Okimoto, Shunji Ishihara, Tamotsu Sugai, Takayuki Matsumoto
    Gut and Liver.2019; 13(1): 62.     CrossRef
  • Chronic enteropathy associated with SLCO2A1 gene: A case report and literature review
    Peng Hu, Huiqin He, Ning Dai, Shizheng Zhang, Liping Deng
    Clinics and Research in Hepatology and Gastroenterology.2019; 43(5): e68.     CrossRef
  • 6,863 View
  • 117 Download
  • 17 Web of Science
  • 19 Crossref
Close layer
IBD
Nonimmunity against hepatitis B virus infection in patients newly diagnosed with inflammatory bowel disease
Seong Jae Yeo, Hyun Seok Lee, Byung Ik Jang, Eun Soo Kim, Seong Woo Jeon, Sung Kook Kim, Kyeong Ok Kim, Yoo Jin Lee, Hyun Jik Lee, Kyung Sik Park, Yun Jin Jung, Eun Young Kim, Chang Heon Yang
Intest Res 2018;16(3):400-408.   Published online July 27, 2018
DOI: https://doi.org/10.5217/ir.2018.16.3.400
AbstractAbstract PDFPubReaderePub
<b>Background/Aims</b><br/>

This study aimed to elucidate the prevalence of hepatitis B virus (HBV) serologic markers in Korean patients newly diagnosed with, but not yet treated for inflammatory bowel disease (IBD).

Methods

We prospectively enrolled 210 patients newly diagnosed with IBD (109 with ulcerative colitis and 101 with Crohn's disease). Hepatitis B surface antigen (HBsAg), hepatitis B surface antibody (anti-HBs), and hepatitis B core antibody (anti-HBc) levels were measured and compared with those of 1,100 sex- and age-matched controls.

Results

The prevalence of chronic HBV infection (positive HBsAg, positive anti-HBc, and negative anti-HBs results) and past infection (negative HBsAg, positive anti-HBc, and positive or negative anti-HBs results) were not significantly different between the patients and controls (chronic HBV infection: IBD, 3.8% vs. control, 4.9%, P=0.596; past infection: IBD, 26.2% vs. control, 28.8%, P=0.625). The patients with IBD aged <20 years were at a higher susceptibility risk (nonimmune) for HBV infection than the controls (IBD, 41.5% vs. control, 22.4%; P=0.018). In the multivariate analysis, an age of <20 years (P=0.024) and symptom duration of ≥12 months before diagnosis (P=0.027) were identified as independent risk factors for nonimmunity against HBV infection.

Conclusions

The patients newly diagnosed with IBD were susceptible to HBV infection. The frequency of nonimmunity was high, especially in the patients aged <20 years and those with a longer duration of symptoms before diagnosis. Therefore, it is necessary to screen for HBV serologic markers and generate a detailed vaccination plan for patients newly diagnosed with IBD.

Citations

Citations to this article as recorded by  
  • Prevalence of hepatitis B virus and hepatitis C virus infection in patients with inflammatory bowel disease: a systematic review and meta-analysis
    Suprabhat Giri, Dhiraj Agrawal, Shivaraj Afzalpurkar, Sunil Kasturi, Amrit Gopan, Sridhar Sundaram, Aditya Kale
    Intestinal Research.2023; 21(3): 392.     CrossRef
  • Viral Hepatitis in Patients with Inflammatory Bowel Disease
    Seung Hwan Shin, Sang Hyoung Park
    The Korean Journal of Gastroenterology.2022; 80(2): 51.     CrossRef
  • Vaccination strategies for Korean patients with inflammatory bowel disease
    Yoo Jin Lee, Eun Soo Kim
    The Korean Journal of Internal Medicine.2022; 37(5): 920.     CrossRef
  • Management of hepatitis B virus infection in patients with inflammatory bowel disease under immunosuppressive treatment
    Georgios Axiaris, Evanthia Zampeli, Spyridon Michopoulos, Giorgos Bamias
    World Journal of Gastroenterology.2021; 27(25): 3762.     CrossRef
  • Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases
    Soo-Kyung Park, Chang Hwan Choi, Jaeyoung Chun, Heeyoung Lee, Eun Sun Kim, Jae Jun Park, Chan Hyuk Park, Bo-In Lee, Yunho Jung, Dong-Il Park, Do Young Kim, Hana Park, Yoon Tae Jeen
    Intestinal Research.2020; 18(1): 18.     CrossRef
  • Evaluating Hepatitis B Seroprotection and Revaccination for Children With Inflammatory Bowel Disease
    Erica J Brenner, Ravi Jhaveri, Michael D Kappelman, Ajay S Gulati
    Inflammatory Bowel Diseases.2019; 25(9): e108.     CrossRef
  • The importance of immunization in immune-mediated inflammatory disease cannot be overstated
    Sang Hyoung Park
    Intestinal Research.2018; 16(3): 325.     CrossRef
  • 6,919 View
  • 97 Download
  • 7 Web of Science
  • 7 Crossref
Close layer
IBD
The association between new generation oral contraceptive pill and the development of inflammatory bowel diseases
Santosh Sanagapalli, Yanna Ko, Viraj Kariyawasam, Siew C Ng, Whitney Tang, Hithanadura Janaka de Silva, Minhu Chen, Kaichun Wu, Satimai Aniwan, Ka Kei Ng, David Ong, Qin Ouyang, Ida Hilmi, Marcellus Simadibrata, Pises Pisespongsa, Saranya Gopikrishna, Rupert W Leong
Intest Res 2018;16(3):409-415.   Published online July 27, 2018
DOI: https://doi.org/10.5217/ir.2018.16.3.409
AbstractAbstract PDFPubReaderePub
<b>Background/Aims</b><br/>

To examine the association between use of oral contraceptive pills (OCPs) and the risk of developing inflammatory bowel diseases (IBD), in a modern cohort.

Methods

A prospective nested case-control study across sites in the Asia-Pacific region was conducted; involving female IBD cases and asymptomatic controls. Subjects completed a questionnaire addressing questions related to OCP use. Primary outcome was the risk of development of IBD of those exposed to OCP versus non-exposure. Secondary outcomes were development of Crohn's disease (CD) versus ulcerative colitis (UC), and whether age of first use of OCP use may be associated with risk of IBD.

Results

Three hundred and forty-eight female IBD cases (41% CD, median age: 43 years) and 590 female age-matched controls were recruited. No significant association was found between OCP use and the risk of IBD (odds ratio [OR], 1.65; 95% confidence interval, 0.77–3.13; P=0.22), CD (OR, 1.55) or UC (OR, 1.01). The lack of association persisted when results were adjusted for age and smoking. IBD cases commenced OCP use at a younger age than controls (18 years vs. 20 years, P=0.049).

Conclusions

In this large cohort of subjects from the Asia-Pacific region, we found a modest but not significantly increased risk of developing IBD amongst OCP users.

Citations

Citations to this article as recorded by  
  • Estrogen receptor actions in colitis
    Erika L. Garcia-Villatoro, Clinton D. Allred
    Essays in Biochemistry.2021; 65(6): 1003.     CrossRef
  • Sex-based differences in inflammatory bowel diseases: a review
    Sheila D. Rustgi, Maia Kayal, Shailja C. Shah
    Therapeutic Advances in Gastroenterology.2020; 13: 175628482091504.     CrossRef
  • 7,218 View
  • 102 Download
  • 3 Web of Science
  • 2 Crossref
Close layer
IBD
The incidence and risk factors of venous thromboembolism in Japanese inpatients with inflammatory bowel disease: a retrospective cohort study
Katsuyoshi Ando, Mikihiro Fujiya, Yoshiki Nomura, Yuhei Inaba, Yuuya Sugiyama, Takuya Iwama, Masami Ijiri, Keitaro Takahashi, Kazuyuki Tanaka, Aki Sakatani, Nobuhiro Ueno, Shin Kashima, Kentaro Moriichi, Yusuke Mizukami, Toshikatsu Okumura
Intest Res 2018;16(3):416-425.   Published online July 27, 2018
DOI: https://doi.org/10.5217/ir.2018.16.3.416
AbstractAbstract PDFPubReaderePub
<b>Background/Aims</b><br/>

Venous thromboembolism (VTE) is a major extraintestinal manifestation in inflammatory bowel disease (IBD), regarded as an independent risk factor for VTE according to reports from Western countries. However, the incidence and risk factors of VTE in Asian IBD patients are not fully understood. We aimed to reveal the incidence and risk factors of VTE in Japanese IBD inpatients.

Methods

The incidence of VTE in inpatients with IBD (n=340), gastrointestinal cancers (n=557), and other gastrointestinal diseases (n=569) treated at our hospital from 2009 to 2013 was retrospectively investigated. The characteristics and laboratory data of IBD inpatients with and without VTE were compared in univariate and multivariate analyses. Clinical courses of VTE in IBD were surveyed.

Results

VTE was detected in 7.1% of IBD inpatients, significantly higher than in gastrointestinal cancer inpatients (2.5%) and inpatients with other gastrointestinal diseases (0.88%). The incidence of VTE in ulcerative colitis (UC) patients (16.7%) was much higher than that in those with Crohn's disease (3.6%). In the univariate analysis, the risk factors were an older age, central venous catheter, prednisolone, surgery, low serum albumin, high serum C-reactive protein and D-dimer. According to a multivariate analysis, >50 years of age and surgery were the only risk factors. The in-hospital mortality rate of IBD inpatients with VTE was 4.2%.

Conclusions

The incidence of VTE with IBD, especially UC, was found to be high compared with other digestive disease, which was almost equivalent to that of Western countries. The efficacy of prophylaxis needs to be investigated in Asian IBD patients.

Citations

Citations to this article as recorded by  
  • Anti-tumor Necrosis Factor Alpha Versus Corticosteroids: A 3-fold Difference in the Occurrence of Venous Thromboembolism in Inflammatory Bowel Disease-A Systematic Review and Meta-analysis
    Hajnal Székely, Laura Mária Tóth, Anett Rancz, Anna Walter, Nelli Farkas, Miklós Domonkos Sárközi, Szilárd Váncsa, Bálint Erőss, Péter Hegyi, Pál Miheller
    Journal of Crohn's and Colitis.2024; 18(5): 773.     CrossRef
  • Extended Post Discharge Prophylaxis for Venous Thromboembolism Prevention After Bariatric Surgery
    Francisco A. Guzman-Pruneda, Ambar Garcia, Robert W. Crum, Theresa Chen, Abraham Krikhely, Marc Bessler
    Obesity Surgery.2024; 34(4): 1217.     CrossRef
  • Predictive Value of Serum Inflammatory Markers on Activity of Ulcerative Colitis
    小梅 马
    Advances in Clinical Medicine.2024; 14(02): 4453.     CrossRef
  • The Journey Through the Pathogenesis and Treatment of Venous Thromboembolism in Inflammatory Bowel Diseases: A Narrative Review
    Andrea Boccatonda, Marco Balletta, Susanna Vicari, Ariela Hoxha, Paolo Simioni, Elena Campello
    Seminars in Thrombosis and Hemostasis.2023; 49(07): 744.     CrossRef
  • Risk of venous thromboembolism with a central venous catheter in hospitalized Japanese patients with inflammatory bowel disease: a propensity score-matched cohort study
    Yasuhiro Aoki, Hiroki Kiyohara, Yohei Mikami, Kosaku Nanki, Takaaki Kawaguchi, Yusuke Yoshimatsu, Shinya Sugimoto, Tomohisa Sujino, Kaoru Takabayashi, Naoki Hosoe, Haruhiko Ogata, Yasushi Iwao, Takanori Kanai
    Intestinal Research.2023; 21(3): 318.     CrossRef
  • Splanchnic Vein Thrombosis in Inflammatory Bowel Disease: An Observational Study from the ENEIDA Registry and Systematic Review
    Maria Puig, Helena Masnou, Francisco Mesonero, Luís Menchén, Luís Bujanda, Jesús Castro, Irene González-Partida, Raquel Vicente, Carlos González-Muñoza, Marisa Iborra, Mónica Sierra, José María Huguet, María José García, Ruth De Francisco, Francisco Javie
    Journal of Clinical Medicine.2023; 12(23): 7366.     CrossRef
  • Preoperative prevalence and risk factors of deep-vein thrombosis in Japanese surgical patients with ulcerative colitis: a retrospective investigational study
    Hiroki Ohya, Hideaki Kimura, Jun Watanabe, Kazuya Nakagawa, Yusuke Suwa, Mayumi Ozawa, Atsushi Ishibe, Reiko Kunisaki, Chikara Kunisaki, Itaru Endo
    Surgery Today.2022; 52(2): 251.     CrossRef
  • Real-World Insurance Claims Analysis of Venous Thromboembolism in Japanese Patients with Inflammatory Bowel Disease
    Mikihiro Fujiya, Tsutomu Kawaguchi, Shoko Arai, Naoki Isogawa, Shintaro Hiro, Fumihiro Matsumoto, Satoshi Yamaguchi, Noritoshi Yoshii, Mashio Nakamura, Katsuyoshi Matsuoka
    Digestive Diseases and Sciences.2022; 67(11): 5195.     CrossRef
  • Venous thromboembolism in chronic gastrointestinal disorders
    Federica Melazzini, Francesca Calabretta, Marco Vincenzo Lenti, Antonio Di Sabatino
    Expert Review of Gastroenterology & Hepatology.2022; 16(5): 437.     CrossRef
  • Venous Thromboembolism Prophylaxis in Inflammatory Bowel Disease: A Two-year Retrospective Study of Patients Presenting With Inflammatory Bowel Disease to a Community Hospital
    Dominic Amakye, Onoriode Kesiena, Ademayowa Ademiluyi, Margaret Gavor, Zahraa Rabeeah
    Cureus.2022;[Epub]     CrossRef
  • Thromboembolism is associated with poor prognosis and high mortality in patients with inflammatory bowel disease: A case–control study
    Yadukrishna S., Saurabh Kedia, Varun Teja, Sudheer Kumar Vuyyuru, Nidhi Yadav, Pabitra Sahu, Saransh Jain, Dawesh P. Yadav, Sawan Bopanna, Venigalla Pratap Mouli, Deepak Madhu, Raju Sharma, Prasenjit Das, Govind Makharia, Vineet Ahuja
    Indian Journal of Gastroenterology.2022;[Epub]     CrossRef
  • Venous thromboembolism in pediatric inflammatory bowel disease: an 11-year population-based nested case–control study in Canada
    Zhaolu Ding, Mary Sherlock, Anthony K.C. Chan, Mary Zachos
    Blood Coagulation & Fibrinolysis.2022; 33(8): 449.     CrossRef
  • Risk of venous thromboembolism in Asian patients with inflammatory bowel disease: a nationwide cohort study
    Chan Mi Heo, Tae Jun Kim, Eun Ran Kim, Sung Noh Hong, Dong Kyung Chang, Mi Yang, Seonwoo Kim, Young-Ho Kim
    Scientific Reports.2021;[Epub]     CrossRef
  • Probiotic-Derived Polyphosphate Accelerates Intestinal Epithelia Wound Healing through Inducing Platelet-Derived Mediators
    Shotaro Isozaki, Hiroaki Konishi, Mikihiro Fujiya, Hiroki Tanaka, Yuki Murakami, Shin Kashima, Katsuyoshi Ando, Nobuhiro Ueno, Kentaro Moriichi, Toshikatsu Okumura, Hirokazu Fukui
    Mediators of Inflammation.2021; 2021: 1.     CrossRef
  • Risk Factors of Venous Thromboembolism in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
    Hua Zhang, Xuehong Wang
    Frontiers in Medicine.2021;[Epub]     CrossRef
  • Perioperative Venous Thromboembolism in Ulcerative Colitis: A Multicenter Prospective Study in Japan
    Michio Itabashi, Hiroki Ikeuchi, Hideaki Kimura, Kohei Fukushima, Hisao Fujii, Riichiro Nezu, Kitaro Futami, Akira Sugita, Yasuo Suzuki, Tadakazu Hisamatsu
    Crohn's & Colitis 360.2021;[Epub]     CrossRef
  • Incidence and risk factors for venous thrombosis among patients with inflammatory bowel disease in China: a multicenter retrospective study
    Jing Liu, Xiang Gao, Ye Chen, Qiao Mei, Liangru Zhu, Jiaming Qian, Pinjin Hu, Qian Cao
    Intestinal Research.2021; 19(3): 313.     CrossRef
  • A nationwide survey concerning the mortality and risk of progressing severity due to arterial and venous thromboembolism in inflammatory bowel disease in Japan
    Katsuyoshi Ando, Mikihiro Fujiya, Kenji Watanabe, Sakiko Hiraoka, Hisashi Shiga, Shinji Tanaka, Hideki Iijima, Tsunekazu Mizushima, Taku Kobayashi, Masakazu Nagahori, Hiroki Ikeuchi, Shingo Kato, Takehiro Torisu, Kiyonori Kobayashi, Masaaki Higashiyama, T
    Journal of Gastroenterology.2021; 56(12): 1062.     CrossRef
  • Prevalence of Asymptomatic Venous Thromboembolism in Depressive Inpatients


    Masahiro Takeshima, Hiroyasu Ishikawa, Yoshiaki Umeta, Mizuki Kudoh, Akise Umakoshi, Kazuhisa Yoshizawa, Yu Ito, Tomoko Hosoya, Ko Tsutsui, Hidenobu Ohta, Kazuo Mishima
    Neuropsychiatric Disease and Treatment.2020; Volume 16: 579.     CrossRef
  • Venous thromboembolism in inflammatory bowel disease
    Kimberly Cheng, Adam S Faye
    World Journal of Gastroenterology.2020; 26(12): 1231.     CrossRef
  • Inflammatory Bowel Disease Therapy and Venous Thromboembolism
    Thomas Lambin, Adam S. Faye, Jean-Frédéric Colombel
    Current Treatment Options in Gastroenterology.2020; 18(3): 462.     CrossRef
  • Clinical Case of Complicated Thrombophilia in a Patient with Ulcerative Colitis
    S. A. Boldueva, I. V. Yarmosh, A. N. Dolinova, Z. G. Kaloeva, M. Yu. Serkova, V. M. Avramova
    Rational Pharmacotherapy in Cardiology.2020; 16(5): 737.     CrossRef
  • Letter: different risks of venous thromboembolism in subsets of patients with inflammatory bowel diseases
    Ru Ding, Jianjiang Xu, Zhiqing He, Yihong Chen, Anna Hultgårdh‐Nilsson, Chun Liang
    Alimentary Pharmacology & Therapeutics.2019; 49(3): 345.     CrossRef
  • Mechanical Thrombectomy as an Initial Treatment for Sinus Thrombosis
    Yusuke Takahashi, Yoshitaka Suda, Ayana Saito, Ryosei Wakasa
    Journal of Neuroendovascular Therapy.2019; 13(12): 507.     CrossRef
  • Ein Infekt unklarer Genese
    Constanze H. Waggershauser
    Gastro-News.2018; 5(5): 6.     CrossRef
  • 7,551 View
  • 193 Download
  • 22 Web of Science
  • 25 Crossref
Close layer
IBD
Selective M1 macrophage polarization in granuloma-positive and granuloma-negative Crohn's disease, in comparison to intestinal tuberculosis
Prasenjit Das, Ritika Rampal, Sonakshi Udinia, Tarun Kumar, Sucharita Pilli, Nahid Wari, Imtiaz Khan Ahmed, Saurabh Kedia, Siddhartha Datta Gupta, Dhiraj Kumar, Vineet Ahuja
Intest Res 2018;16(3):426-435.   Published online July 27, 2018
DOI: https://doi.org/10.5217/ir.2018.16.3.426
AbstractAbstract PDFPubReaderePub
<b>Background/Aims</b><br/>

Classical M1 macrophage activation exhibits an inflammatory phenotype while alternative M2 macrophage activation exhibits an anti-inflammatory phenotype. We aimed to determine whether there are discriminant patterns of macrophage polarization in Crohn's disease (CD) and intestinal tuberculosis (iTB).

Methods

Colonic mucosal biopsies from 29 patients with iTB, 50 with CD, and 19 controls were examined. Dual colored immunohistochemistry was performed for iNOS/CD68 (an M1φ marker) and CD163/CD68 (an M2φ marker), and the ratio of M1φ to M2φ was assessed. To establish the innate nature of macrophage polarization, we analyzed the extent of mitochondrial depolarization, a key marker of inflammatory responses, in monocyte-derived macrophages obtained from CD and iTB patients, following interferon-γ treatment.

Results

M1φ polarization was more prominent in CD biopsies (P=0.002) than in iTB (P=0.2) and control biopsies. In granuloma-positive biopsies, including those in CD, M1φ predominance was significant (P=0.001). In iTB, the densities of M1φ did not differ between granuloma-positive and granuloma-negative biopsies (P=0.1). Interestingly, higher M1φ polarization in CD biopsies correlated with high inflammatory response exhibited by peripheral blood-derived monocytes from these patients.

Conclusions

Proinflammatory M1φ polarization was more common in colonic mucosa of CD patients, especially in the presence of mucosal granulomas. Further characterization of the innate immune system could help in clarifying the pathology of iTB and CD.

Citations

Citations to this article as recorded by  
  • Macrophage polarization: an important role in inflammatory diseases
    Min Luo, Fukun Zhao, Huan Cheng, Mu Su, Yuanmin Wang
    Frontiers in Immunology.2024;[Epub]     CrossRef
  • The gut barrier as a gatekeeper in colorectal cancer treatment
    Roy Hajjar, Carole Richard, Manuela M. Santos
    Oncotarget.2024; 15(1): 562.     CrossRef
  • New diagnostic strategies to distinguish Crohn's disease and gastrointestinal tuberculosis
    Himanshu Narang, Saurabh Kedia, Vineet Ahuja
    Current Opinion in Infectious Diseases.2024; 37(5): 392.     CrossRef
  • Differentiating gastrointestinal tuberculosis and Crohn's disease- a comprehensive review
    Arup Choudhury, Jasdeep Dhillon, Aravind Sekar, Pankaj Gupta, Harjeet Singh, Vishal Sharma
    BMC Gastroenterology.2023;[Epub]     CrossRef
  • Clinical Usefulness of Immune Profiling for Differential Diagnosis between Crohn’s Disease, Intestinal Tuberculosis, and Behcet’s Disease
    Ji Won Yoo, Su In Jo, Dong Woo Shin, Ji Won Park, Sung-Eun Kim, Hyun Lim, Ho Suk Kang, Sung-Hoon Moon, Min Kyu Kim, Sang-Yeob Kim, Sung Wook Hwang, Jae Seung Soh
    Diagnostics.2023; 13(18): 2904.     CrossRef
  • Production of granulomas in Mycoplasma bovis infection associated with meningitis-meningoencephalitis, endocarditis, and pneumonia in cattle
    Mathurot Suwanruengsri, Ryoko Uemura, Takuya Kanda, Naoyuki Fuke, Phawut Nueangphuet, Apisit Pornthummawat, Masahiro Yasuda, Takuya Hirai, Ryoji Yamaguchi
    Journal of Veterinary Diagnostic Investigation.2022; 34(1): 68.     CrossRef
  • Human M1 macrophages express unique innate immune response genes after mycobacterial infection to defend against tuberculosis
    Arshad Khan, Kangling Zhang, Vipul K. Singh, Abhishek Mishra, Priyanka Kachroo, Tian Bing, Jong Hak Won, Arunmani Mani, Ramesha Papanna, Lovepreet K. Mann, Eder Ledezma-Campos, Genesis Aguillon-Duran, David H. Canaday, Sunil A. David, Blanca I. Restrepo,
    Communications Biology.2022;[Epub]     CrossRef
  • Lacticaseibacillus casei Strain Shirota Modulates Macrophage-Intestinal Epithelial Cell Co-Culture Barrier Integrity, Bacterial Sensing and Inflammatory Cytokines
    Andrew Foey, Neama Habil, Alex Strachan, Jane Beal
    Microorganisms.2022; 10(10): 2087.     CrossRef
  • Biomaterial-based osteoimmunomodulatory strategies via the TLR4-NF-κB signaling pathway: A review
    Haiyuan Xing, Ruiyan Li, Yun'an Qing, Boda Ying, Yanguo Qin
    Applied Materials Today.2021; 22: 100969.     CrossRef
  • Two ST11 Klebsiella pneumoniae strains exacerbate colorectal tumorigenesis in a colitis-associated mouse model
    Ming-Ko Chiang, Pei-Yi Hsiao, Yen-Yi Liu, Hui-Ling Tang, Chien-Shun Chiou, Min-Chi Lu, Yi-Chyi Lai
    Gut Microbes.2021;[Epub]     CrossRef
  • A combination of circulating microRNA-375-3p and chemokines CCL11, CXCL12, and G-CSF differentiate Crohn’s disease and intestinal tuberculosis
    Susree Roy, Suchandrima Ghosh, Mallica Banerjee, Sayantan Laha, Dipanjan Bhattacharjee, Rajib Sarkar, Sujay Ray, Arko Banerjee, Ranajoy Ghosh, Aniket Halder, Alakendu Ghosh, Raghunath Chatterjee, Simanti Datta, Gopal Krishna Dhali, Soma Banerjee
    Scientific Reports.2021;[Epub]     CrossRef
  • Arsenic trioxide alleviates acute graft-versus-host disease by modulating macrophage polarization
    Xiao Liu, Yan Su, Xueyan Sun, Haixia Fu, Qiusha Huang, Qi Chen, Xiaodong Mo, Meng Lv, Yuan Kong, Lanping Xu, Xiaojun Huang, Xiaohui Zhang
    Science China Life Sciences.2020; 63(11): 1744.     CrossRef
  • Heterogeneous macrophages: Supersensors of exogenous inducing factors
    Caiyun Qian, Zehui Yun, Yudi Yao, Minghua Cao, Qiang Liu, Song Hu, Shuhua Zhang, Daya Luo
    Scandinavian Journal of Immunology.2019;[Epub]     CrossRef
  • Understanding Pathogenesis and Care Challenges of Immune Reconstitution Inflammatory Syndrome in Fungal Infections
    Sarah Dellière, Romain Guery, Sophie Candon, Blandine Rammaert, Claire Aguilar, Fanny Lanternier, Lucienne Chatenoud, Olivier Lortholary
    Journal of Fungi.2018; 4(4): 139.     CrossRef
  • 11,284 View
  • 130 Download
  • 14 Web of Science
  • 14 Crossref
Close layer
IBD
What nutritional factors influence bone mineral density in Crohn's disease patients?
Fernanda Gomes Coqueiro, Raquel Rocha, Camilla Almeida Menezes, Mirella Brasil Lopes, Vanessa Rosa Oliveira, Flora Maria Lorenzo Fortes, Genoile Oliveira Santana
Intest Res 2018;16(3):436-444.   Published online July 27, 2018
DOI: https://doi.org/10.5217/ir.2018.16.3.436
AbstractAbstract PDFPubReaderePub
<b>Background/Aims</b><br/>

Bone mineral density (BMD) is often low in patients with Crohn's disease (CD). This study aimed to evaluate the association between nutritional factors and BMD in a group of CD patients.

Methods

CD patients 18 years of age or older were included. The body mass index (BMI), waist circumference (WC) and dietary intake were evaluated during two 24-hour recalls. Bone densitometry was performed by dual-energy X-ray absorptiometry of the full body to assess body composition and of the lumbar vertebrae and femoral neck to assess BMD.

Results

In the 60 patients evaluated, there was no association between BMD and disease activity or between BMD and disease duration. We observed moderate correlations between BMD in at least one of the evaluated sites and BMI, lean mass, WC, and protein, calcium, phosphorus and magnesium dietary intakes (P<0.05). In the linear regression analysis for spinal BMD, only BMI and calcium dietary intake remained associated (P<0.05). In the linear regression analysis for femoral BMD, WC and phosphorus intake continued to be significant in the final model, although they had low explanatory power for BMD (P<0.05).

Conclusions

The prevalence of low BMD was high in CD patients. BMI, WC, calcium and phosphorus dietary intake were positively correlated with BMD.

Citations

Citations to this article as recorded by  
  • The Effect of Protein Nutritional Support on Inflammatory Bowel Disease and Its Potential Mechanisms
    Qingye Li, Jing Wang
    Nutrients.2024; 16(14): 2302.     CrossRef
  • Assessment of dietary nutrient intake and its relationship to the nutritional status of patients with Crohn’s Disease in Guangdong Province of China
    Hong Zheng, Xinbin Chen, Xiaoling Bu, Xia Qiu, Demeng Zhang, Yitong Zhou, Junlong Lin, Jinghong Li, Wenjun Ma, Ying Zheng
    Nutrición Hospitalaria.2023;[Epub]     CrossRef
  • Serum N-terminal telopeptide of type I collagen as a biomarker for predicting bone density loss in patients with Crohn disease
    Natsuki Ishida, Tomohiro Higuchi, Takahiro Miyazu, Satoshi Tamura, Satoshi Suzuki, Shinya Tani, Mihoko Yamade, Moriya Iwaizumi, Yasushi Hamaya, Satoshi Osawa, Takahisa Furuta, Ken Sugimoto, Mathilde Body-Malapel
    PLOS ONE.2021; 16(4): e0250658.     CrossRef
  • Osteoporosis Complications in Crohn's Disease Patients: Factors, Pathogenesis, and Treatment Outlines
    Yaqot N Baban, Christopher M Edicheria, Joseph Joseph, Parneet Kaur, Jihan A Mostafa
    Cureus.2021;[Epub]     CrossRef
  • Crohn Disease and Fracture Risk Assessment With FRAX
    Grethe B Jonasson, Jack Hilon, Bengt Hasseus, Torgny Alstad, Hossein Kashani
    Crohn's & Colitis 360.2019;[Epub]     CrossRef
  • 5,991 View
  • 71 Download
  • 5 Web of Science
  • 5 Crossref
Close layer
IBD
Magnetic resonance enterography predicts the prognosis of Crohn's disease
Ji Hoon Lee, Yong Eun Park, Nieun Seo, Hyun Jung Lee, Soo Jung Park, Tae Il Kim, Won Ho Kim, Joon Seok Lim, Jae Hee Cheon
Intest Res 2018;16(3):445-457.   Published online July 27, 2018
DOI: https://doi.org/10.5217/ir.2018.16.3.445
AbstractAbstract PDFPubReaderePub
<b>Background/Aims</b><br/>

Magnetic resonance enterography (MRE) has emerged as an important tool in the diagnosis and follow-up of Crohn's disease (CD). The aim of this study was to evaluate whether MRE findings could predict the prognosis of CD.

Methods

In this retrospective study, a total of 173 patients with clinical remission of CD (n=61) or active CD (n=112) were identified. The outcomes of clinical relapse, admission, surgery, and need for other medications according to the MRE findings were evaluated.

Results

The presence of active inflammation on MRE was observed in 93 (83%) patients with clinically active CD and in 44 (72.1%) patients with clinical remission of CD, without a statistically significant difference (P=0.091). In multivariate analysis, active inflammation on MRE increased the risk for clinical relapse (hazard ratio [HR], 6.985; 95% confidence interval [CI], 1.024–47.649) in patients with clinical remission of CD. In patients with clinically active CD, active inflammation on MRE increased the risk for CD-related hospitalization (HR, 2.970; 95% CI, 1.006–8.772).

Conclusions

The presence of active inflammation on MRE was significantly associated with poor prognosis both in patients with clinical remission of CD and in those with active CD.

Citations

Citations to this article as recorded by  
  • The Spectrum of Magnetic Resonance Enterography Findings and the Role of Diffusion-Weighted Imaging in Patients with Active Crohn’s Disease
    Arvin Arian, Ghazal Roostaei, Seyede Sahel Rasoulighasemlouei, Foroogh Alborzi Avanaki, Nasser Ebrahimi Daryani
    Middle East Journal of Digestive Diseases.2024; 16(1): 23.     CrossRef
  • Distribution of small bowel involvement and its association with clinical outcomes in patients with Crohn’s disease
    Jin Park, Hae Young Kim, Yoon Jin Lee, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee
    Medicine.2023; 102(40): e35040.     CrossRef
  • Combined Endoscopic and Radiologic Healing Is Associated With a Better Prognosis Than Endoscopic Healing Only in Patients With Crohn's Disease Receiving Anti-TNF Therapy
    Kyunghwan Oh, Eun Hye Oh, Soo Min Noh, Seong Ho Park, Nayoung Kim, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye
    Clinical and Translational Gastroenterology.2022; 13(1): e00442.     CrossRef
  • MR Enterography in Crohnʼs Disease: Comparison of Contrast Imaging with Diffusion-weighted Imaging and a special Form of Color Coding
    Maja Jakob, Maik Backes, Christian Schaefer, Joerg Albert, Angela Geissler
    RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.2022; 194(10): 1119.     CrossRef
  • Crohn’s disease at radiological imaging: focus on techniques and intestinal tract
    Giuseppe Cicero, Silvio Mazziotti
    Intestinal Research.2021; 19(4): 365.     CrossRef
  • Radiological Response Is Associated with Better Outcomes and Should Be Considered a Therapeutic Target in Crohn’s Disease
    Eléonore Hallé, Mustapha Azahaf, Nicolas Duveau, Thomas Lambin, Maria Nachury, Julien Branche, Romain Gérard, Clémentine Lauriot Dit Prevost, Pauline Wils, Pierre Desreumaux, Olivier Ernst, Benjamin Pariente
    Digestive Diseases and Sciences.2020; 65(9): 2664.     CrossRef
  • Magnetic Resonance Enterography and Capsule Endoscopy in Patients Undergoing Patency Capsule for the Evaluation of Small Bowel Crohn’s Disease: A Korean Clinical Experience
    Hyun Seok Lee, Yun Jeong Lim, Jin-Hee Jung, Ji Hyung Nam, Junseok Park, Sun Hyung Kang, Ki Bae Kim, Hoon Jai Chun
    Gastroenterology Research and Practice.2020; 2020: 1.     CrossRef
  • Beyond Crohn Disease
    Michael S. Furman, Edward Y. Lee
    Radiologic Clinics of North America.2020; 58(3): 517.     CrossRef
  • Mucosal healing in Crohn’s disease: new insights
    Salvatore Cucchiara, Giulia D’Arcangelo, Sara Isoldi, Marina Aloi, Laura Stronati
    Expert Review of Gastroenterology & Hepatology.2020; 14(5): 335.     CrossRef
  • Changes in the Management of Patients with Crohn’s Disease Based on Magnetic Resonance Enterography Patterns
    Evelyn Sayuri S. Chinem, Barbara C. Esberard, Andre da L. Moreira, Tatiana G. Barbassa, Guilherme M. da Cunha, Antonio Jose de V. Carneiro, Heitor S. de Souza, Ana Teresa P. Carvalho
    Gastroenterology Research and Practice.2019; 2019: 1.     CrossRef
  • 6,978 View
  • 104 Download
  • 9 Web of Science
  • 10 Crossref
Close layer
Miscellaneous
Risk factors for severity of colonic diverticular hemorrhage
Ken Kinjo, Toshiyuki Matsui, Takashi Hisabe, Hiroshi Ishihara, Toshiki Kojima, Kenta Chuman, Shigeyoshi Yasukawa, Tsuyoshi Beppu, Akihiro Koga, Satoshi Ishikawa, Masahiro Kishi, Noritaka Takatsu, Fumihito Hirai, Kenshi Yao, Toshiharu Ueki, Masakazu Washio
Intest Res 2018;16(3):458-466.   Published online July 27, 2018
DOI: https://doi.org/10.5217/ir.2018.16.3.458
AbstractAbstract PDFPubReaderePub
<b>Background/Aims</b><br/>

Colonic diverticular hemorrhage (DH) was a rare disease until the 1990s, and its incidence has increased rapidly since 2000 in Japan. In recent years, colonic DH has been the most frequent cause of lower gastrointestinal bleeding (LGIB). Nearly all cases of DH are mild, with the bleeding often stopping spontaneously. Some cases, however, require surgery or arterial embolization. In this study, using a cohort at Fukuoka University Chikushi Hospital, we investigated factors associated with severe colonic DH.

Methods

Among patients with LGIB who underwent colonoscopy at our hospital between 1995 and 2013, DH was identified in 273 patients. Among them, 62 patients (22.7%) were defined as having severe colonic DH according to recurrence of bleeding in a short period, and/or the necessity of transfusion, arterial embolization, or surgery. We then evaluated risk factors for severe DH among DH patients in this retrospective cohort.

Results

Among the 273 patients with DH, use of non-steroidal anti-inflammatory drugs (NSAIDs) (odds ratio [OR], 2.801; 95% confidence interval [CI], 1.164–6.742), Charlson Risk Index (CRI) ≥2 (OR, 3.336; 95% CI, 1.154–7.353), right-sided colonic DH (OR, 3.873; 95% CI, 1.554–9.653), and symptoms of cerebral hypoperfusion (such as light-headedness, dizziness, or syncope) (OR, 2.926; 95% CI, 1.310–6.535) showed an increased risk of severe DH even after controlling for other factors.

Conclusions

Severe DH occurred in 23% of DH patients, and NSAID use, CRI ≥2, right-sided colonic DH, and symptoms of cerebral hypoperfusion are suggested to be predictors of severe DH.

Citations

Citations to this article as recorded by  
  • Clinical Factors Associated with Severity of Colonic Diverticular Bleeding and Impact of Bleeding Site
    Hirohito Amano, Takatsugu Yamamoto, Ken Ikusaka, Naoaki Aoki, Miyoko Sakurai, Taku Honda, Kyohei Maruyama, Hitoshi Aoyagi, Akari Isono, Koichiro Abe, Yoshinari Asaoka, Shinya Kodashima, Atsushi Tanaka
    Journal of Clinical Medicine.2023; 12(5): 1826.     CrossRef
  • Effectiveness and Safety of Endoscopic Submucosal Dissection for Colorectal Neoplasm in Patients with High Charlson Comorbidity Index Score: A HASID Multicenter Study
    Dong-Hyun Kim, Yong-Wook Jung, Byung-Chul Jin, Hyung-Hoon Oh, Hyo-Yeop Song, Seong-Jung Kim, Dae-Seong Myung, Sang-Wook Kim, Jun Lee, Geom-Seog Seo, Young-Eun Joo, Hyun-Soo Kim
    Journal of Clinical Medicine.2023; 12(19): 6255.     CrossRef
  • Risk factors for patients hospitalized with recurrent colon diverticular bleeding: a single center experience
    Hye-Su You, Dong Hyun Kim, Seo-Yeon Cho, Seon-Young Park, Chang Hwan Park, Hyun-Soo Kim, Sung Kyu Choi
    Frontiers in Medicine.2023;[Epub]     CrossRef
  • Construction of a Model for Predicting the Severity of Diverticular Bleeding in an Elderly Population
    Tomoyuki Okada, Tsuyoshi Mikamo, Ayana Nakashima, Atsushi Yanagitani, Kiwamu Tanaka, Hajime Isomoto
    Internal Medicine.2022; 61(15): 2247.     CrossRef
  • Diagnosis and Treatment of Colonic Diverticular Disease
    You Sun Kim
    The Korean Journal of Gastroenterology.2022; 79(6): 233.     CrossRef
  • Development and Validation of Predictive Assessment of Complicated Diverticulitis Score
    Marcello Covino, Valerio Papa, Antonio Tursi, Benedetta Simeoni, Loris Riccardo Lopetuso, Lorenzo Maria Vetrone, Francesco Franceschi, Gianludovico Rapaccini, Antonio Gasbarrini, Alfredo Papa
    Journal of Personalized Medicine.2021; 11(2): 80.     CrossRef
  • Risk of Rebleeding in Patients with Small Bowel Vascular Lesions
    Akira Harada, Takehiro Torisu, Shin Fujioka, Yuichiro Yoshida, Yasuharu Okamoto, Yuta Fuyuno, Atsushi Hirano, Junji Umeno, Kumiko Torisu, Tomohiko Moriyama, Motohiro Esaki, Takanari Kitazono
    Internal Medicine.2021; 60(23): 3663.     CrossRef
  • Vegetarianism as a protective factor for asymptomatic colonic diverticulosis in Asians: a retrospective cross-sectional and case-control study
    Jihun Bong, Hyoun Woo Kang, Hyeki Cho, Ji Hyung Nam, Dong Kee Jang, Jae Hak Kim, Jun Kyu Lee, Yun Jeong Lim, Moon-Soo Koh, Jin Ho Lee
    Intestinal Research.2020; 18(1): 121.     CrossRef
  • 9,005 View
  • 127 Download
  • 9 Web of Science
  • 8 Crossref
Close layer
Colorectal neoplasia
Clinical significance of carcinoembryonic antigen in peritoneal fluid detected during operation in stage I–III colorectal cancer patients
Jae Hyun Kim, Seunghun Lee, Seung Hyun Lee, Byung Kwon Ahn, Sung Uhn Baek, Won Moon, Seun Ja Park
Intest Res 2018;16(3):467-474.   Published online July 27, 2018
DOI: https://doi.org/10.5217/ir.2018.16.3.467
AbstractAbstract PDFPubReaderePub
<b>Background/Aims</b><br/>

Early diagnosis of peritoneal metastases in patients with colorectal cancer (CRC) can influence patient prognosis. The aim of this study was to identify the clinical significance of carcinoembryonic antigen (CEA) in peritoneal fluid detected during operation in stage I–III CRC patients.

Methods

Between April 2009 and April 2015, we reviewed medical records from a total of 60 stage I–III CRC patients who had peritoneal fluid collected during operation. Patients who had positive cytology in the assessment of peritoneal fluid were excluded. We evaluated the values of CEA in peritoneal fluid (pCEA) to predict the long-term outcomes of these patients using Kaplan-Meier curves and Cox regression models.

Results

The median follow-up duration was 37 months (interquartile range, 21–50 months). On receiver operating characteristic analysis, pCEA had the largest area under the curve (0.793; 95% confidence interval, 0.635–0.950; P=0.001) with an optimal cutoff value of 26.84 (sensitivity, 80.0%; specificity, 76.6%) for predicting recurrence. The recurrence rate was 8.1% in patients with low pCEA (<26.84 ng/mL, n=37), and 52.2% in patients with high pCEA (≥26.84 ng/mL, n=23). In multivariate Cox regression analysis, high pCEA (≥26.84 ng/mL) was a risk factor for poor cancer-free survival (CFS) in stage I–III patients.

Conclusions

In this study, we determined that high pCEA (≥26.84 ng/mL) detected during operation was helpful for the prediction of poor CFS in patients with stage I–III CRC.

Citations

Citations to this article as recorded by  
  • Evaluation of peritoneal Carcinoembryonic Antigen as a survival prognostic factor in gastric cancer patients: a single western center experience
    Nicola Natalizi, Elisabetta Marino, Luigina Graziosi, Annibale Donini
    Updates in Surgery.2023; 75(5): 1211.     CrossRef
  • Prognostic Significance of Preoperative Serum Carcinoembryonic Antigen Varies with Lymph Node Metastasis Status in Colorectal Cancer
    Jing Jia, MinZhe Li, Wenhao Teng, Lin Wang, Weidong Zang, Jun Xiao, Ying Chen, Dan Zhao
    Journal of Oncology.2021; 2021: 1.     CrossRef
  • 8,900 View
  • 85 Download
  • 2 Web of Science
  • 2 Crossref
Close layer
Endoscopy
Histologic discrepancy between endoscopic forceps biopsy and endoscopic mucosal resection specimens of colorectal polyp in actual clinical practice
Moon Joo Hwang, Kyeong Ok Kim, A Lim Kim, Si Hyung Lee, Byung Ik Jang, Tae Nyeun Kim
Intest Res 2018;16(3):475-483.   Published online July 27, 2018
DOI: https://doi.org/10.5217/ir.2018.16.3.475
AbstractAbstract PDFPubReaderePub
<b>Background/Aims</b><br/>

We aimed to assess the rate of histologic discrepancy (HD) between endoscopic forceps biopsy (EFB) and totally resected specimens in colorectal polyp and analyze the risk factors of discordant group, especially under-diagnosis (UD) cases before complete removal of colorectal polyp.

Methods

From 2010 to 2015, a total of 290 polyps in 210 patients which had baseline pathology report before endoscopic resection (ER) were analyzed. UD cases were defined as those in which the diagnosis changed to a more advanced histologic feature after ER.

Results

A change in the final histology after ER was noted in 137 cases (47.2%), and after excluding 9 insignificant cases, 128 cases were further categorized into over-diagnosed and under-diagnosed group. UD occurred in 86 cases (29.7%) and change from benign to malignancy was noted in 26 cases (8.9%). On univariate analysis, a larger polyp size (>10 mm) was significantly associated with both HD (P<0.001) and UD (P<0.001). Regarding polyp morphology, protruding or flat was not significantly important. On multivariate analysis, polyp size >10 mm was the single most significant predictor of both HD (P<0.001) and UD (P<0.001).

Conclusions

The HD and UD rates were 47.2% and 29.7%, respectively. Polyp size >10 mm was the most important predictor of both HD and UD. We should be careful in making treatment strategy of colorectal polyp based on histologic report of EFB especially when the size of polyp is >10 mm.

Citations

Citations to this article as recorded by  
  • Comparing efficacy and factors of postoperative bleeding in endoscopic mucosal resection vs coagulation for intestinal polyps
    Zhiang Li, Fei Yu, Chaoqian Wang, Zhang Du
    Medicine.2023; 102(37): e34941.     CrossRef
  • “Unresectable” polyp management utilizing advanced endoscopic techniques results in high rate of colon preservation
    Carey J. Wickham, Jennifer Wang, Kasim L. Mirza, Erik R. Noren, Joongho Shin, Sang W. Lee, Kyle G. Cologne
    Surgical Endoscopy.2022; 36(3): 2121.     CrossRef
  • Potential Factors Predicting Histopathologically Upgrade Discrepancies between Endoscopic Forceps Biopsy of the Colorectal Low-Grade Intraepithelial Neoplasia and Endoscopic Resection Specimens
    Junbo Hong, Yining Wang, Jiangshan Deng, Miao Qi, Wei Zuo, Yuanzheng Hao, Anjiang Wang, Yi Tu, Shan Xu, Xiaodong Zhou, Xiaojiang Zhou, Guohua Li, Liang Zhu, Xu Shu, Yin Zhu, Nonghua Lv, Youxiang Chen, Li-kang Sun
    BioMed Research International.2022; 2022: 1.     CrossRef
  • Endoscopic vs optical biopsy for patients with colorectal lesions: prospective multicentral trial
    K.D. Khalin, M.Yu. Agapov, E.D. Fedorov, L.V. Zvereva, N.E. Ogurchyonok, K.V. Stegnii, E.V. Ivanova, E.R. Dvoinikova, E.V. Gorbachev
    Dokazatel'naya gastroenterologiya.2022; 11(3): 11.     CrossRef
  • Long-term Outcomes of Primary Endoscopic Resection vs Surgery for T1 Colorectal Cancer: A Systematic Review and Meta-analysis
    Jen-Hao Yeh, Cheng-Hao Tseng, Ru-Yi Huang, Chih-Wen Lin, Ching-Tai Lee, Po-Jen Hsiao, Tsung-Chin Wu, Liang-Tseng Kuo, Wen-Lun Wang
    Clinical Gastroenterology and Hepatology.2020; 18(12): 2813.     CrossRef
  • Prophylactic endoscopic coagulation to prevent delayed post-EMR bleeding in the colorectum: a prospective randomized controlled trial (with videos)
    Hyun Seok Lee, Seong Woo Jeon, Yong Hwan Kwon, Su Youn Nam, Seonghwan Shin, Ryanghi Kim, Sohyun Ahn
    Gastrointestinal Endoscopy.2019; 90(5): 813.     CrossRef
  • 7,862 View
  • 94 Download
  • 4 Web of Science
  • 6 Crossref
Close layer
Case Reports
IBD
Successful remission of ulcerative colitis flare-up during pregnancy with adsorptive granulomonocytapheresis plus tacrolimus
Tomoyoshi Shibuya, Keiichi Haga, Masato Kamei, Koki Okahara, Shoko Ito, Masahito Takahashi, Osamu Nomura, Takashi Murakami, Masae Makino, Tomohiro Kodani, Dai Ishikawa, Naoto Sakamoto, Taro Osada, Tatsuo Ogihara, Sumio Watanabe, Akihito Nagahara
Intest Res 2018;16(3):484-488.   Published online July 27, 2018
DOI: https://doi.org/10.5217/ir.2018.16.3.484
AbstractAbstract PDFPubReaderePub

Ulcerative colitis (UC) is 1 of the 2 major phenotypes of chronic inflammatory bowel disease (IBD), which afflicts millions of individuals throughout the world with debilitating symptoms that impair function and quality of life. Further, IBD often affects women during childbearing age. Indeed, UC activity frequently increases during pregnancy, and the medications used to induce remission may adversely affect the health of the mother and the unborn child. We report successful induction of a remission in a UC case who experienced a flare-up in the first trimester of pregnancy. Upon relapse, she was treated with steroids and adsorptive granulomonocytapheresis (GMA) with the Adacolumn plus tacrolimus. This combination therapy induced a stable remission that was maintained during her entire pregnancy. She gave birth to a healthy child at 36 weeks of pregnancy with no maternal or fetal complications. Our experience indicates that GMA, as a non-drug therapeutic intervention with a favorable safety profile, plus tacrolimus might be a relevant treatment option for patients with active IBD during pregnancy. A future study of a large cohort of pregnant patients should strengthen our findings.

Citations

Citations to this article as recorded by  
  • Adsorptive cytapheresis in ulcerative colitis: A non‐pharmacological therapeutic approach revisited
    Filippo Vernia, Angelo Viscido, Giovanni Latella
    Journal of Clinical Apheresis.2023; 38(6): 746.     CrossRef
  • Apheresis: A cell-based therapeutic tool for the inflammatory bowel disease
    Farah Yasmin, Hala Najeeb, Unaiza Naeem, Abdul Moeed, Thoyaja Koritala, Salim Surani
    World Journal of Clinical Cases.2022; 10(21): 7195.     CrossRef
  • Reproductive Health in IBD Patients
    Sanket Patel, Haleh Vaziri
    Current Treatment Options in Gastroenterology.2021; 19(2): 237.     CrossRef
  • Selective granulocyte and monocyte apheresis in inflammatory bowel disease: Its past, present and future
    Xiu-Li Chen, Jing-Wei Mao, Ying-De Wang
    World Journal of Gastrointestinal Pathophysiology.2020; 11(3): 43.     CrossRef
  • Women’s Health and Ulcerative Colitis
    Kindra Clark-Snustad, Madalina Butnariu, Anita Afzali
    Gastroenterology Clinics of North America.2020; 49(4): 769.     CrossRef
  • 9,904 View
  • 109 Download
  • 3 Web of Science
  • 5 Crossref
Close layer
IBD
Enteric infections complicating ulcerative colitis
Dejan Micic, Ayal Hirsch, Namrata Setia, David T. Rubin
Intest Res 2018;16(3):489-493.   Published online July 27, 2018
DOI: https://doi.org/10.5217/ir.2018.16.3.489
AbstractAbstract PDFPubReaderePub

Enteric infections have previously been postulated to play a role in the pathogenesis of inflammatory bowel disease (IBD), however, little evidence exists in the etiologic role of specific enteric infections in the development of IBD. When encountered in the setting of IBD, enteric infections pose a clinical challenge in management given the competing treatment strategies for infectious conditions and autoimmune disorders. Here we present the case of a young male with enteric infections complicating a new diagnosis of IBD. Our patient's initial clinical presentation included diagnoses of Klebsiella oxytoca isolation and Clostridium difficile infection. Directed therapies to include withdrawal of antibiotics and fecal microbiota transplantation were performed without resolution of clinical symptoms. Given persistence of symptoms and active colitis, the patient was diagnosed with ulcerative colitis (UC), requiring treatments directed at severe UC to include cyclosporine therapy. The finding of multiple enteric infections in a newly presenting patient with IBD is an unexpected finding that has treatment implications.

Citations

Citations to this article as recorded by  
  • Echinacea purpurea Polysaccharide Ameliorates Dextran Sulfate Sodium-Induced Colitis by Restoring the Intestinal Microbiota and Inhibiting the TLR4-NF-κB Axis
    Fan-Hao Wei, Wen-Yin Xie, Pei-Sen Zhao, Wei Gao, Fei Gao
    Nutrients.2024; 16(9): 1305.     CrossRef
  • Inflammatory bowel disease complicated with rare pathogen infection
    Jia-Heng Fang, Guo-Xiong Li
    World Chinese Journal of Digestology.2023; 31(1): 8.     CrossRef
  • Usefulness of Stool Multiplex Polymerase Chain Reaction Assays in Patients with Acute Diarrhea
    Seo Hyun Kim, You Sun Kim, Seung Hyuk Kim, Won Eui Yoon, Hee Jun Myung, Jeong Seop Moon, Dong Hee Whang
    The Korean Journal of Gastroenterology.2022; 79(3): 118.     CrossRef
  • Animal unit hygienic conditions influence mouse intestinal microbiota and contribute to T-cell-mediated colitis
    Mariana Cázares-Olivera, Dominika Miroszewska, Lili Hu, Jacek Kowalski, Ulla-Marjut Jaakkola, Seppo Salminen, Bin Li, Emrah Yatkin, Zhi Chen
    Experimental Biology and Medicine.2022; 247(19): 1752.     CrossRef
  • Gut Microbiota-Mediated NLRP12 Expression Drives the Attenuation of Dextran Sulphate Sodium-Induced Ulcerative Colitis by Qingchang Wenzhong Decoction
    Zhongmei Sun, Wenjing Pei, Yi Guo, Zhibin Wang, Rui Shi, Xiaowei Chen, Xingjie Zhao, Chen Chen, Jiali Liu, Xiang Tan, Wenjing Yuan, Tangyou Mao
    Evidence-Based Complementary and Alternative Medicine.2019; 2019: 1.     CrossRef
  • Intestinal autophagy links psychosocial stress with gut microbiota to promote inflammatory bowel disease
    Shu-Ling Wang, Bo-Zong Shao, Sheng-Bing Zhao, Xin Chang, Pei Wang, Chao-Yu Miao, Zhao-Shen Li, Yu Bai
    Cell Death & Disease.2019;[Epub]     CrossRef
  • 6,489 View
  • 99 Download
  • 5 Web of Science
  • 6 Crossref
Close layer
Brief Communication
IBD
Effect of elemental diet combined with infliximab dose escalation in patients with Crohn's disease with loss of response to infliximab: CERISIER trial
Tadakazu Hisamatsu, Reiko Kunisaki, Shiro Nakamura, Tomoyuki Tsujikawa, Fumihito Hirai, Hiroshi Nakase, Kenji Watanabe, Kaoru Yokoyama, Masakazu Nagahori, Takanori Kanai, Makoto Naganuma, Hirofumi Michimae, Akira Andoh, Akihiro Yamada, Tadashi Yokoyama, Noriko Kamata, Shinji Tanaka, Yasuo Suzuki, Toshifumi Hibi, Mamoru Watanabe
Intest Res 2018;16(3):494-498.   Published online July 27, 2018
DOI: https://doi.org/10.5217/ir.2018.16.3.494
PDFSupplementary MaterialPubReaderePub

Citations

Citations to this article as recorded by  
  • Prospective study of an adalimumab combined with partial enteral nutrition in the induction period of Crohn’s disease
    Sisi Zhou, Zeyu Huang, Wenjing Hou, Yiting Lin, Jing Yu
    Inflammation Research.2024; 73(2): 199.     CrossRef
  • Role of diet in prevention versus treatment of Crohn’s disease and ulcerative colitis
    Emma P Halmos, Lihi Godny, Julie Vanderstappen, Chen Sarbagili-Shabat, Vaios Svolos
    Frontline Gastroenterology.2024; : flgastro-2023-102417.     CrossRef
  • Immunoregulatory Effects of Elemental Diet and Its Ingredient, Tryptophan, via Activation of the Aryl Hydrocarbon Receptor in Mice
    Atsuhito Kubota, Shungo Imai, Ryoichi Aoyagi, Wataru Murase, Masaru Terasaki, Mitsuru Sugawara, Yoh Takekuma, Hiroyuki Kojima
    International Journal of Molecular Sciences.2024; 25(6): 3448.     CrossRef
  • Real-world evidence of combined treatment of biologics and exclusive enteral nutrition in patients with ileum-dominant Crohn's disease: A multicenter study
    Wei Wang, Anning Yin, Jing Wang, Jiao Li, Jingyun Cheng, Jian Kang, Yaqing Xu, Yueyue Lu, Yuanping Yang, Juan Su, Qian Zhou, Ya Liu, Zhishun Tang, Haixia Ren, Weiwei Li, Weiguo Dong, Baoping Yu, Ping An
    Clinical Nutrition.2024; 43(6): 1291.     CrossRef
  • It’s Time to Change Tack in IBD Treatment
    Marcel A. Behr, Ildiko Mehes, Charles N. Bernstein
    Gastroenterology.2024;[Epub]     CrossRef
  • "Out of the box� new therapeutic strategies for Crohn�s disease: moving beyond biologics
    Ignacio Catalán-Serra, Pret Ricanek, Tore Grimstad
    Revista Española de Enfermedades Digestivas.2022;[Epub]     CrossRef
  • Nutritional Therapy Strategies in Pediatric Crohn’s Disease
    Charlotte M. Verburgt, Mohammed Ghiboub, Marc A. Benninga, Wouter J. de Jonge, Johan E. Van Limbergen
    Nutrients.2021; 13(1): 212.     CrossRef
  • Evidence-based clinical practice guidelines for inflammatory bowel disease 2020
    Hiroshi Nakase, Motoi Uchino, Shinichiro Shinzaki, Minoru Matsuura, Katsuyoshi Matsuoka, Taku Kobayashi, Masayuki Saruta, Fumihito Hirai, Keisuke Hata, Sakiko Hiraoka, Motohiro Esaki, Ken Sugimoto, Toshimitsu Fuji, Kenji Watanabe, Shiro Nakamura, Nagamu I
    Journal of Gastroenterology.2021; 56(6): 489.     CrossRef
  • Diet and nutrition in the management of inflammatory bowel disease
    Pabitra Sahu, Saurabh Kedia, Vineet Ahuja, Rakesh K. Tandon
    Indian Journal of Gastroenterology.2021; 40(3): 253.     CrossRef
  • Nutritional Aspects of Pediatric Gastrointestinal Diseases
    Teresa Di Chio, Christiane Sokollik, Diego G. Peroni, Lara Hart, Giacomo Simonetti, Franziska Righini-Grunder, Osvaldo Borrelli
    Nutrients.2021; 13(6): 2109.     CrossRef
  • Efficacy and tolerability of exclusive enteral nutrition in adult patients with complicated Crohn’s disease
    Sanchit Sharma, Arti Gupta, Saurabh Kedia, Samagra Agarwal, Namrata Singh, Sandeep Goyal, Saransh Jain, Vipin Gupta, Pabitra Sahu, Sudheer Kumar Vuyyuru, Bhaskar Kante, Raju Sharma, Rajesh Panwar, Peush Sahni, Govind Makharia, Vineet Ahuja
    Intestinal Research.2021; 19(3): 291.     CrossRef
  • Nutritional Therapies and Their Influence on the Intestinal Microbiome in Pediatric Inflammatory Bowel Disease
    Lara Hart, Charlotte M. Verburgt, Eytan Wine, Mary Zachos, Alisha Poppen, Mallory Chavannes, Johan Van Limbergen, Nikhil Pai
    Nutrients.2021; 14(1): 4.     CrossRef
  • Efficacy of enteral nutrition in patients with Crohn’s disease on maintenance anti-TNF-alpha antibody therapy: a meta-analysis
    Fumihito Hirai, Teruyuki Takeda, Yasumichi Takada, Masahiro Kishi, Tsuyoshi Beppu, Noritaka Takatsu, Masaki Miyaoka, Takashi Hisabe, Kenshi Yao, Tosiharu Ueki
    Journal of Gastroenterology.2020; 55(2): 133.     CrossRef
  • Inflammatory Bowel Disease in Japan-Is It Similar to or Different from Westerns?-
    Shinji Okabayashi, Taku Kobayashi, Toshifumi Hibi
    Journal of the Anus, Rectum and Colon.2020; 4(1): 1.     CrossRef
  • Exclusive enteral nutrition for induction of remission in anti-tumor necrosis factor refractory adult Crohn’s disease: the Indian experience
    Ajit Sood, Arshdeep Singh, Ritu Sudhakar, Vandana Midha, Ramit Mahajan, Varun Mehta, Yogesh Kumar Gupta, Kirandeep Kaur
    Intestinal Research.2020; 18(2): 184.     CrossRef
  • Enteral nutrition in the biologic era: learn from yesterday, live for today, hope for tomorrow
    Tadakazu Hisamatsu
    Intestinal Research.2020; 18(2): 139.     CrossRef
  • Half-Elemental Diet Shifts the Human Intestinal Bacterial Compositions and Metabolites: A Pilot Study with Healthy Individuals
    Jun Miyoshi, Daisuke Saito, Mio Nakamura, Miki Miura, Tatsuya Mitsui, Toru Kudo, Shinnosuke Murakami, Minoru Matsuura, Tadakazu Hisamatsu
    Gastroenterology Research and Practice.2020; 2020: 1.     CrossRef
  • Fool me once… treatment exposure to achieve remission in pediatric IBD
    Johan E. Van Limbergen, Bart G. P. Koot, J. Peter de Winter
    European Journal of Pediatrics.2020; 179(12): 1921.     CrossRef
  • Bases for the Adequate Development of Nutritional Recommendations for Patients with Inflammatory Bowel Disease
    Esteban Sáez-González, Beatriz Mateos, Pedro López-Muñoz, Marisa Iborra, Inés Moret, Pilar Nos, Belén Beltrán
    Nutrients.2019; 11(5): 1062.     CrossRef
  • 6,470 View
  • 143 Download
  • 18 Web of Science
  • 19 Crossref
Close layer
Corrigenda and Errata
Corrigendum: Tofacitinib induction and maintenance therapy in East Asian patients with active ulcerative colitis: subgroup analyses from three phase 3 multinational studies
Satoshi Motoya, Mamoru Watanabe, Hyo Jong Kim, Young Ho Kim, Dong Soo Han, Hirotoshi Yuasa, Junichi Tabira, Naoki Isogawa, Shoko Arai, Isao Kawaguchi, Toshifumi Hibi
Intest Res 2018;16(3):499-501.   Published online July 27, 2018
DOI: https://doi.org/10.5217/ir.2018.16.3.499
PDFPubReaderePub

Citations

Citations to this article as recorded by  
  • Post-inflammatory Abdominal Pain in Patients with Inflammatory Bowel Disease During Remission: A Comprehensive Review
    Kazuya Takahashi, Iman Geelani Khwaja, Jocelyn Rachel Schreyer, David Bulmer, Madusha Peiris, Shuji Terai, Qasim Aziz
    Crohn's & Colitis 360.2021;[Epub]     CrossRef
  • Two cases in which tofacitinib effectively treated both ulcerative colitis and alopecia areata
    Oki Kikuchi, Daisuke Saito, Miki Miura, Haruka Wada, Ryo Ozaki, Sotaro Tokunaga, Shintaro Minowa, Masahiro Fukuyama, Tatsuya Mitsui, Akihito Sakuraba, Mari Hayashida, Jun Miyoshi, Minoru Matsuura, Manabu Ohyama, Tadakazu Hisamatsu
    Clinical Journal of Gastroenterology.2020; 13(5): 788.     CrossRef
  • Tuberculosis and targeted synthetic or biologic DMARDs, beyond tumor necrosis factor inhibitors
    Gerasimos Evangelatos, Vasiliki Koulouri, Alexios Iliopoulos, George E Fragoulis
    Therapeutic Advances in Musculoskeletal Disease.2020; 12: 1759720X2093011.     CrossRef
  • RETRACTED: Crystal structure, anti-cervical cancer activity and docking studies of a new heterocycles compound
    Peng Li, Xin Ge, Hong-Li Wu
    Main Group Chemistry.2019; 18(2): 63.     CrossRef
  • 4,801 View
  • 68 Download
  • 5 Web of Science
  • 4 Crossref
Close layer
Letters to the Editor
Endoscopy
Surveillance colonoscopy in patients with sessile serrated adenoma
Ji Hyung Nam, Hyoun Woo Kang
Intest Res 2018;16(3):502-503.   Published online July 27, 2018
DOI: https://doi.org/10.5217/ir.2018.16.3.502
PDFPubReaderePub
  • 5,085 View
  • 81 Download
Close layer
Images of the Issue
Infection
Cytomegalovirus colitis in immunocompetent patients
Jae Ho Park, Hee Seok Moon
Intest Res 2018;16(3):504-505.   Published online July 27, 2018
DOI: https://doi.org/10.5217/ir.2018.16.3.504
PDFPubReaderePub

Citations

Citations to this article as recorded by  
  • Acute cytomegalovirus infection modulates the intestinal microbiota and targets intestinal epithelial cells
    Vu Thuy Khanh Le‐Trilling, Jana‐Fabienne Ebel, Franziska Baier, Kerstin Wohlgemuth, Kai Robin Pfeifer, Aart Mookhoek, Philippe Krebs, Madita Determann, Benjamin Katschinski, Alexandra Adamczyk, Erik Lange, Robert Klopfleisch, Christian M. Lange, Viktoriya
    European Journal of Immunology.2023;[Epub]     CrossRef
  • The Overlooked Agent: Cytomegalovirus Colitis in an Immunocompetent Patient
    Margarida Lagarto, Ana Santos, Bruno D Freitas, Marta Anastácio, Susana Jesus
    Cureus.2023;[Epub]     CrossRef
  • Cytomegalovirus hemorrhagic colitis in an immunocompetent patient with COVID-19 infection: A case report
    Neha Mehta, Sangam Shah, Madhur Bhattarai, Rajan Chamlagain, Amir Joshi, Ashish Mehta, Dinesh Koirala
    SAGE Open Medical Case Reports.2023;[Epub]     CrossRef
  • Cytomegalovirus enteritis with intractable diarrhea in infants from a tertiary care center in China
    Yuhuan Wang, Zhiheng Huang, Ziqing Ye, Cuifang Zheng, Zhinong Jiang, Ying Huang
    Scandinavian Journal of Gastroenterology.2020; 55(1): 55.     CrossRef
  • Unremitting diarrhoea in a girl diagnosed anti-N-methyl-D-aspartate-receptor encephalitis: A case report
    Norrapat Onpoaree, Montida Veeravigrom, Anapat Sanpavat, Narissara Suratannon, Palittiya Sintusek
    World Journal of Clinical Cases.2020; 8(20): 4866.     CrossRef
  • 6,688 View
  • 192 Download
  • 5 Web of Science
  • 5 Crossref
Close layer

Intest Res : Intestinal Research
Close layer
TOP